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RÉSUMÉ 
Le rôle des protéines de surface dans l’infection des bactériophages de Clostridium 
difficile. 
Maicol Ospina Bedoya. Programme de microbiologie. Mémoire présentée à la Faculté de 
médecine et des sciences de la santé en vue de l’obtention du diplôme de maitre ès sciences 
(M.Sc.) en microbiologie, Faculté de médecine et des sciences de la santé, Université de 
Sherbrooke, Sherbrooke, Québec, Canada, J1H 5N4 
 
Les phages sont des parasites bactériens présents dans tous les types d’écosystèmes et ont un 
effet important sur le cycle de vie des cellules procaryotes. Malgré l’importance des 
bactériophages dans la biologie bactérienne, leur fonction dans le cycle de vie de Clostridium 
difficile n’a pas encore été étudié de manière exhaustive. C. difficile est un pathogène 
bactérien préoccupant qui cause des infections intestinales sévères chez les humains et les 
animaux. Dans ce travail, nous investiguons le rôle de deux protéines de surface, CwpV et 
SlpA, dans l’infection de C. difficile par des bactériophages. La fonction de la protéine SlpA 
n’est pas entièrement connue. Un possible rôle dans l’infection par des bactériophages a déjà 
été suggéré sans toutefois avoir d’évidences expérimentales. C. difficile est susceptible à 
l’infection par des bactériophages, les récepteurs utilisés par ceux-ci sont toutefois inconnus. 
CwpV est la plus grosse protéine de la famille des protéines CWP chez C. difficile. CwpV 
possède une région variable en C-terminal qui est constituée de séquences répétées dont la 
séquence et le nombre varient selon la souche de C. difficile étudiée. Comme premier objectif, 
nous utilisons l’hôte hétérologue Lactococcus lactis afin de transférer l’effet de la protéine 
CwpV comme mécanisme de défense contre l’infection par des bactériophages. Un effet 
protecteur de la protéine CwpV contre le bactériophage p2 chez L. lactis NZ9000 (EOP = 
4,4x10-2) a été noté. De plus, des essais de survie bactérienne ont montré une réduction de la 
susceptibilité au bactériophage p2 des souches de L. lactis exprimant la protéine CwpV 
(environ 60%). L’expression de cette protéine n’empêche toutefois pas l’adsorption du 
bactériophage p2 sur la bactérie (92,8 ± 1,0 % pour le contrôle et 91,5 ± 2,9 % pour la souche 
test), ce qui suggère que CwpV n’interfère pas lors de l’interaction entre le récepteur primaire 
et le bactériophage. Dans la deuxième partie de cette étude, nous montrons par l’utilisation 
d’un mutant slpA- issus de la souche épidémique R20291 que l’absence de la protéine SlpA 
à la surface de la cellule rend la bactérie insensible à l’infection par trois bactériophages 
appartenant à la famille des Siphoviridae: ϕCD38-2, ϕCD111 et ϕCD146. La 
complémentation du mutant slpA- avec l’allèle de type sauvage rétabli la susceptibilité à 
l’infections par ces bactériophages. La réintroduction de cinq allèles provenant de différentes 
souches de C. difficile chez le mutant slpA- confère aussi une susceptibilité à d’autres 
bactériophages de la famille des Myoviridae qui n’infectent pas normalement la souche 
R20291. Finalement, la co-expression de deux allèles de la protéine SlpA dans la souche 
sauvage R20291 (types 4 et 12) confère une double sensibilité aux bactériophages des deux 
différentes familles. L’objectif de recherche de ce travail est d’approfondir et de comprendre 
à plus large échelle la relation hôte-bactériophage du point de vue des protéines de surface 
de C. difficile.  
Mots clés: Clostridium difficile, Lactococcus lactis, bactériophage, CwpV, système 
d’antiphage, SlpA, récepteur 
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SUMMARY 
The role of surface layer proteins in Clostridium difficile bacteriophage infection 
Maicol Ospina Bedoya. Microbiology Program. Thesis presented at the Faculty of medicine 
and health sciences for the obtention of Master degree diploma (M.Sc.) in Microbiology, 
Faculty of medicine and health sciences, Université de Sherbrooke, Sherbrooke, Québec, 
Canada, J1H 5N4 
 
Phages are bacterial parasites that are present in virtually all ecosystems and have a massive 
effect on the life cycle of bacterial cells. Despite the importance of bacteriophages in bacterial 
biology, their function in the biology of Clostridium difficile has not been extensively 
studied. C. difficile is an important bacterial pathogen that causes severe intestinal infections 
in humans and animals. With this work, we seek to understand the role of two closely related 
surface layer proteins, CwpV and SlpA in C. difficile bacteriophage infection. The function 
of SlpA is still not completely understood. A possible role in bacteriophage infection has 
been suggested, although experimental evidence is lacking. C. difficile is prone to infection 
by bacteriophages, and the bacterial receptors used by these bacteriophages are unknown. 
CwpV is the largest protein of the C. difficile Cwp family. The variable region of CwpV is 
located toward the C-terminal end, and it is composed of a serine-glycine enriched flexible 
linker which is followed by repetitive sequences, whose sequence and number change 
depending on the C. difficile strain. The N-terminal domain possesses the cell-wall anchoring 
activity. Like SlpA, the CwpV protein undergoes maturation into two subunits that are re-
associated in a non-covalent manner that forms a heterodimeric complex. Based on previous 
data from our lab on CwpV, the first objective of this study involved the use of the 
heterologous host Lactococcus lactis to transfer the antiphage functionality of CwpV against 
a new bacteriophage. We observed that the expression of CwpV conferred antiphage 
protection against bacteriophage p2 in L. lactis NZ9000 (EOP= 4.4x10-2). Additionally, 
bacterial survival assays showed a reduced susceptibility to p2 bacteriophage infection in L. 
lactis expressing CwpV (around 60 %). Also, the adsorption of bacteriophage p2 is not 
prevented in cells expressing cwpV, suggesting that CwpV does not block a primary 
bacteriophage receptor (92.8 ± 1.0 % for the control and 91.5 ± 2.9 % for the test strain). 
Using a slpA- mutant derived from the epidemic strain R20291, in the second part of our 
study, we show that the absence of SlpA from the cell surface renders the bacterium 
completely insensitive to infection by three related bacteriophages of the Siphoviridae 
family: ϕCD38-2, ϕCD111, and ϕCD146. Complementation of the mutant with a wild-type 
slpA allele restored susceptibility to bacteriophage infection. The reintroduction of five 
alleles conferred susceptibility to other bacteriophages of the Myoviridae family that 
typically do not infect the R20291 strain. Finally, co-expression of the slpA types 4 and12 in 
R20291 confers double susceptibility to bacteriophages of two different viral families. The 
main objective of this work was to better understand and examine on a broader level 
bacteriophage-host interactions through the surface layer proteins of C. difficile.  
Keywords: Clostridium difficile, Lactococcus lactis, bacteriophage, CwpV, antiphage 
system, SlpA, phage receptor 
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CHAPTER I  
INTRODUCTION 
1.1. Brief insights into Clostridium difficile history  
 
Although humans are not the sole organisms fighting against bacteria, in recent years science 
has been working on different flanks to find new weapons that can be used in the battle 
against the oldest inhabitants of the planet Earth. Obviously, regarding human health, the 
microorganisms that can cause diseases are the ones who receive the most attention. 
However, it is important to clarify that most of the microbes that abide in our body cannot 
cause disease. On the contrary, several can protect us against other microorganisms that can 
be harmful or cause an alteration in the health state of an individual. A pathogen is an 
infectious organism that can cause disease in a susceptible host. A particular case is depicted 
when some of these microorganisms only reach their quality as pathogens when its host 
suffers an alteration of the immune system or a modification of other protective factors that 
maintain it in a stable health state. This kind of organism is called opportunistic pathogen 
(NHI, 2007). 
 
Clostridium difficile is an opportunistic pathogen in healthcare-associated infections that was 
discovered in 1935. However, it was only associated with a particular disease in humans in 
1979. After that and during the next three decades, extensive clinical research completely 
associated C. difficile as the primary origin of CDAD (Clostridium difficile associated 
diarrhea) and posterior PMC (pseudomembranous colitis). Additionally, Clostridium difficile 
infection (CDI) was linked to antibiotic exposure in patients in Western countries. In the past, 
CDIs were never considered as a real menace to public health. Usually, epidemics were small 
and mortality and economic burden were never significant (Rupnik & Mastrantonio, 2016). 
Two prominent outbreaks in Canada and the USA in 2003 by the strain named C. difficile 
BI/ NAP1/027 delimited a new epidemic age in which bacterial infections caused by C. 
difficile would play a significant role (Rupnik & Mastrantonio, 2016). 
 
1.1.1 Importance of Clostridium difficile research 
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The reemergence of new C. difficile strains brought economic problems to the health care 
systems, and in parallel, high virulence, escalation in incidence, mortality, and severity was 
progressively detected. Previous findings have evidenced C. difficile as one of the most 
important nosocomial-associated pathogens (along with Escherichia coli, Staphylococcus 
aureus, and Pseudomonas aeruginosa) and equally CDI as one of the major public health 
concerns around the world (Cartman, Heap, Kuehne, Cockayne, & Minton, 2010). 
 
Preoccupation about the future of C. difficile epidemics is rising due to new reports showing 
modification of the infection pattern from an opportunistic microorganism usually affecting 
elderly people and hospitalized patients under antibiotherapy, to a pathogen affecting patients 
with underlying clinical conditions, younger patients, and individuals without previous 
antibiotic exposure. Equally alarming, C. difficile infections are proliferating to the animal 
population, primarily animals utilized for food production (pigs being the most affected due 
to antibiotic overuse). Reports of contaminated vegetables, livestock and meats have worried 
scientist and health administration entities regarding the possibility of CDI as a food 
transmitted zoonosis (Rupnik & Mastrantonio, 2016). 
 
C. difficile is a Gram-positive, bacillus-shaped, spore-forming strictly anaerobic bacterium. 
When the bacterial cells are under stress, they produce spores that are capable of resisting 
extreme conditions that metabolically active bacteria cannot tolerate. The spores can remain 
inactive, but once established in the human intestine, the spores can germinate and cause 
disease. The disease range from mild clinical effects to severe diarrhea and ultimately can 
degenerate into PMC (Rupnik, Wilcox, & Gerding, 2009).  
 
A meta-analysis using PUBMED and EMBASE databases shows that around 8% of patients 
admitted to hospitals are carriers of toxinogenic C. difficile strains with almost six times 
higher risk of illness compared with patients that are admitted but not colonized 
(Zacharioudakis, Zervou, Pliakos, Ziakas, & Mylonakis, 2015). Contaminated hands, clinical 
instruments, and asymptomatic adult patients are not the sole reservoirs for the transmission 
of C. difficile within hospital facilities. Babies can also be colonized by bacteria with an 
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asymptomatic presence and act as reservoirs as well (Rousseau et al., 2012). In the last 
decade, it has been demonstrated that the gut microbiota (the network of microorganisms that 
abide in the gastrointestinal tissue) plays a major role in the physiological stability of the 
host, contributing to the gut health. C. difficile population dynamics is limited and controlled 
by the presence of other significant anaerobic bacteria. Recently, it has been shown that the 
capability of C. difficile to infect and colonize a host depends mostly on the inability of the 
normal gut population to retain C. difficile expansion through the intestinal cavity (Britton & 
Young, 2014; Buffie et al., 2014). Colonization is a vital part of the development of the 
disease and can happen because of the exposure to broad-spectrum antibiotics. It is well 
understood from various studies that older people, peripartum women, and children, 
immunocompromised patients and individuals with recent surgeries tend to have higher CDI 
susceptibility (Block, 2001; Cózar-Llistó, Ramos-Martinez, & Cobo, 2016). 
 
Even with the upcoming of antibiotic cocktails and the development of better targeted 
antibiotic therapies (through the amelioration of patient diagnosis), one of the main 
characteristics of CDIs is the high recurrence rate (i.e., failure in the CDI contention by the 
first antibiotic treatment). These recurrences can result from relapses of the first infecting 
bacteria or reinfections from other C. difficile strains (Bien, Palagani, & Bozko, 2013; Rupnik 
et al., 2009).  
 
1.1.2 Epidemics and evolution of Clostridium difficile 
 
C. difficile epidemic behavior has changed in the last millennium. Over the history, CDI cases 
were underrepresented, and when they were occurring they were related to various types of 
strains. After the year 2000, numerous cases and clinical isolates have been evaluated 
(equally as the strain distribution on the continents) indicating the reemergence of specific 
strains belonging to the hypervirulent BI/NAP1/027 group. This lineage has been detected 
and monitored across Europe and North America (it has spread in several western countries). 
The strains belonging to this cluster are characterized by an overproduction of toxins A and 
B, production of a binary toxins and resistance to fluoroquinolone antibiotics. These changes 
led to an increase in the morbidity and mortality (McDonald et al., 2005; O’Connor, Johnson, 
& Gerding, 2009; Warny et al., 2005). However, in the last years, there has been a debate 
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regarding the mode of hypervirulence in the BI/NAP1/027 group. Other factors such as 
motility, antibiotic resistance, adherence, and sporulation can be added to the emergence of 
epidemic strains from this group (M. Merrigan et al., 2010; Stabler et al., 2009).  
 
Across Canada, numerous studies have followed the historical development, morbidity, and 
mortality of CDI, where interestingly the province of Quebec takes a local relevance. 
Retrospective research of CDI in a period starting in 1991 and finishing in 2003 showed an 
increase in the incidence from 35.6 cases per 100,000 residents to 156.3 cases per 100,000 
residents, respectively. With a similar pattern in the same period, the rate of complications 
during infection treatment increased from 7.1% to 18% (Pépin et al., 2004). A later study in 
hospitals mainly from Sherbrooke and Montreal metropolitan areas reported an incidence of 
22.5 per 1,000 admissions and a 30-day attributable mortality rate of 6.8%. For the studied 
cases, a predominant strain from the group BI/NAP1/027 (82.2 percent of the cases) resistant 
to fluoroquinolones was found (Loo et al., 2005). 
 
One of the latest studies performed in the country assessing the incidence, medical cost, and 
loss of productivity resulting from CDI, estimated that for the year 2012 there were around 
37,932 cases. From there, Quebec had one of the highest numbers of bed days attributable to 
CDIs (5,560,668 bed days). Of those patients, around 73% were newly infected people, and 
27% were recurrence cases. Sixty-one percent were cases with mild to moderate symptoms, 
and 54% of the patients were 75 years old or more. Quebec presents the highest estimated 
number of CDI of all Canadian provinces and territories with 16,562 cases (numbers far 
superior to equally developed provinces like Ontario, British Columbia, and Alberta) 
(Freeman et al., 2010; Levy et al., 2015).  
 
Presently, the epidemic group BI/NAP1/027 is diminishing in proportion, and CDI has been 
caused by different strains (Poxton, 2013). This phenomenon also includes new strains from 
the 078 PCR-ribotype groups which both can be found in human patients and animals for 
meat production (Goorhuis et al., 2008; Knetsch et al., 2014). 
 
1.1.3.  Pathogenesis of Clostridium difficile infections 
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As we previously stated, resident gut microbiota alteration permits spore germination and 
colonization of the host intestinal cavity. This process starts with the vegetative cell of C. 
difficile that, after metabolic activation, evades the host immune system and multiplies. The 
production of toxins and virulence factors start finally causing clinical manifestation (Figure 
1). In that order of ideas, it is important to understand the virulence factors and main 
structural features that are critical in colonization and other steps of the disease progression.  
 
 
1.2. Clostridium difficile virulence factors 
 
 
Figure 1. C. difficile transmission cycle. Original spore exposure from various sources 
does not inevitably result in disease in a healthy human. A healthy microbiota is capable 
of blocking C. difficile spore germination and vegetative growth. However, if the 
microbial ecology of the gut has been disturbed, spore germination and toxin production 
will emerge. The start of the life cycle activation can result in epithelial damage, 
inflammation, and apparent disease as the toxin production takes place. C. difficile 
sporulation, spore release into the environment, and transmission to new individuals 
continues the infectious cycle. Image taken from (Seekatz & Young, 2014). 
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After metabolic activation and establishment of the infection, one of the major virulence 
factors are produced, the exotoxins TcdA and TcdB. Both genes are located in a region of 
the bacterial chromosome called pathogenicity locus or PaLoc (Monot et al., 2015). The 
initial step of the intoxication process starts when the C-terminal receptor domain of the 
protein interacts with the cellular receptor (it is known that both toxins can activate a clathrin-
mediated endocytosis. Also, it has been shown that the poliovirus receptor-like 3 (PVRL3) 
functions as a cellular factor essential for TcdB-mediated cytotoxicity). This interaction 
promotes the endocytosis of the toxins and posterior trafficking via endosomes. Acidification 
of the endosomal compartment and autocatalytic cleavage leads to the liberation of the active 
N-terminus into the cytosol. These domains inactivate numerous members of the Rho 
GTPases family which affect critical downstream cellular processes resulting in a loss of 
cytoskeleton integrity (Awad, Johanesen, Carter, Rose, & Lyras, 2014). Regarding the 
phenotypical manifestation of the cellular intoxication, the toxic effect could be compared to 
the outcome caused by cell apoptosis (Just et al., 1995). The PaLoc also encodes three 
accessory proteins named TcdR, TcdC, and TcdE. TcdE has been speculated to be involved 
in the release of TcdA and TcdB through permeabilization of the cell-wall. TcdR is an 
alternative sigma factor and TcdC may function as a negative regulator of toxin production. 
However, the functions of these accessory proteins remain in part controversial and are still 
investigated (Awad et al., 2014; Voth & Ballard, 2005). 
 
In addition to the toxins, there are other factors like the endospore, flagella, pili, surface layer 
proteins, cell-wall proteins and adhesins that are equally implicated in the C. difficile 
virulence (Awad et al., 2014; Janoir, 2016b). Even if TcdA and TcdB are the primary 
virulence factors of C. difficile, other putative virulence factors may play a role in important 
steps of colonization, the establishment of the disease and the adherence to epithelial cells. 
However, these factors are also an integral part of the cellular structure and architecture of 
the C. difficile cell-wall, interaction with the environment and displacement. Some of them 
will be discussed in the following section.  
 
1.3. Clostridium difficile cell surface architecture 
 
1.3.1. SlpA protein 
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SlpA protein (for Surface-Layer Protein A) is composed of two subunits, the LMW-SLP 
(low-molecular-weight S-layer protein) and the HMW-SLP (high-molecular weight S-layer 
protein), both are a major component of the para-crystalline S-layer of C. difficile (E Calabi 
et al., 2001). The two subunits are produced from the cleavage of the protein precursor SlpA 
by the cysteine protease Cwp84 (described below in section 1.3.6.1) (Bruxelle et al., 2016; 
Dang et al., 2010). Both subunits are noncovalently re-associated after the protease action 
(R.P. Fagan, Albesa-Jove, Qazi, Brown K.A., & Fairweather, 2009) (Figure 2). 
 
 
It has been proposed that SlpA presence has a structural role in the integrity of the bacterial 
shape. Different experiments have also demonstrated that both, natural SlpA proteins and 
recombinant SlpA, can dock to the cells from the cell line Hep-2 and also to human 
gastrointestinal tissues taken from healthy patients (Emanuela Calabi, Calabi, Phillips, & 
Fairweather, 2002). In addition, it has been proven that SlpA proteins are essential in bacterial 
 
Figure 2. The Clostridium difficile cell wall architecture is mainly composed by a 
single protein, SlpA. This protein and other cell wall proteins have a dedicated secretion 
path (SecA2). SlpA undergoes a cleavage event, mediated by a cell wall cysteine protease 
Cwp84, forming the HMW and LMW SLPs which form the assembled S-layer. Image 
modified from (Reynolds et al., 2011a) 
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adherence to the colonic cell line Caco-2. Pre-incubation of bacteria with antibodies against 
LMW-SLP or HMW-SLP reduced adherence to Caco2 cells (M. M. Merrigan et al., 2013). 
Additionally, HMW-SLP presents an in vitro capability to attach to proteins such as type I 
collagen, vitronectin and thrombospondin (Emanuela Calabi et al., 2002). LMW-SLP and 
HMW-SLP domains can activate the host innate immune system, through the recognition of 
Toll-Like Receptors 4 (TLR-4). This activation stimulates signaling pathways that lead to 
maturation of dendritic cells and macrophage activation. However, the immunomodulatory 
kinetics of the SlpA proteins does not happen to correlate with the strain virulence 
considering that no particular immunomodulatory pattern has been discovered for the 
epidemic strain BI/ NAP1/027 when compared to more classical strains (Bianco et al., 2011; 
Poxton, 2013; Vohra & Poxton, 2012). 
 
Studies of the phylogeny of 58 C. difficile isolates based on the core genome (genes common 
to all samples) showed the historical five clades of the population structure as determined 
using MLST data (K. E. Dingle et al., 2013). This pattern was also conserved in genes 
neighboring the cwp cluster (this cluster is explained in the section 1.3.6). However, in 
regions surrounding the genes slpA, cwp66, and secA2, an entirely dissimilar strain 
relationship appeared. A neighbor-joining phylogenetic tree of the slpA gene of the 58 
isolates identified 12 distinct clusters (Figure 3), different from the usual five clades. Equally, 
neighbor-joining trees for the cwp66 adhesin and secA2 translocase grouped these 58 isolates 
identically to slpA. These results indicate that slpA, cwp66, and secA2 coevolve as an 
independent 10-kb gene cassette, which contains at least 12 genetically divergent variants 
(K. E. Dingle et al., 2013). Our understanding of the role of SlpA in CDI (and in other fields 
like bacteriophage infection and virus susceptibility) has been limited by the failure to obtain 
a mutant, despite several attempts by different research groups. Nevertheless, using 
genetically modified contractile R-type bacteriocins (phage-like particles) from C. difficile 
strain CD4 to kill BI/NAP1/027-type strains (Gebhart et al., 2015), a group from AvidBiotics 
Corp. isolated the first mutant for the slpA gene in the epidemic strain R20291 (unpublished 
data at the time of writing these lines). This mutant has an adenine insertion early in the 
sequence of the gene (nucleotide position 98) that leads to a premature TAA stop codon, 
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creating a truncated protein (personal communication from Gregory Govoni, AvidBiotics 
Corp., South San Francisco, California, USA).  
 
 
1.3.2 Polysaccharides 
 
 
Figure 3. Phylogeny of whole genomes and slpA. Phylogeny created from the whole 
genomes: Black forms indicate the clades. Phylogeny constructed from the slpA gene: 
Shapes specify the clade, and colors designate the S-layer variants. Hybrids are indicated 
by a H and a star. Numbers indicate bootstrap support. Image taken from (Dingle et al., 
2013). 
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In metabolically active C. difficile cells, it has been described three types of polysaccharides, 
PSI, PSII, and PSIII, including relevant ribotypes like 027, which has been found to contain 
more PSII than the other two kinds of molecules (Monteiro et al., 2013). Importantly, the 
presence of these molecules has stimulated the production of vaccines and technics for their 
use in diagnosis. Vaccines containing PSII have been tested in different animal models 
(Awad et al., 2014). The same molecule has been used in saccharide microarrays to detect 
IgG antibodies in the sera of CDI patients (Martin et al., 2013). Interestingly, new works in 
a mouse model and a PSII glycoprotein conjugated to TcdA and TcdB fragments indicated 
that antibodies targeting PSII and toxins were produced by mice, this result indicates that a 
combination of sugars and proteins could be a promising topic for vaccine development 
(Romano et al., 2014). 
 
1.3.3. Flagella 
 
C. difficile is motile due to the action of the flagellar machinery. A plethora of diseases-
related bacteria relies on flagella as an important virulence factor (helping in tissue invasion 
and host colonization). Genes that regulate the assembly of the C. difficile flagella are ordered 
into three operons (Awad et al., 2014; Janoir, 2016a). The F3 locus comprises just early stage 
genes and contains the FliA sigma factor (also named SigD). FliA regulates the expression 
of late-stage flagellar genes from the F1 locus, such as genes coding for the flagellin FliC 
and the cap protein FliD. The F2 regulon is responsible for post-translational modification of 
flagella proteins that have been shown indispensable for efficient flagellar assembly and 
motility of C. difficile. The three loci show variability among lineages of C. difficile. 
Interestingly, the F3 locus is not present in the emerging virulent 078 clades, signifying in 
some manner that flagella and therefore motility are unessential for C. difficile virulence 
(Janoir, 2016a). One study has even shown that fliD mutants were more virulent than the 
wild-type strain (Baban et al., 2013). More data is necessary to understand the precise role 
of the flagellar machinery in the virulence of C. difficile. 
 
1.3.4. Fimbriae and pilli 
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Fimbriae are not exclusive to C. difficile strains. In other bacteria, such as E. coli, Bordetella 
pertussis, Staphylococcus and Streptococcus species, the expression of fimbriae is correlated 
with the ability of bacteria to attach to the host and cause disease (Connell et al., 1996). 
However, different studies showed no correlation between serious human or animal epidemic 
strains, expression of fimbriae and their ability to cause disease (Borriello et al., 1988). These 
results suggest that at least in C. difficile, the expression is not necessarily prominent in the 
development of the disease. On the other hand, bioinformatic investigation on the 
phylogenetic class Clostridia shows that in the genome sequences of the microorganism 
belonging to this taxon there are several putative type IV pilus genes (Melville & Craig, 
2013). Specifically, in the epidemic strains 630 and R20291 at least nine pilli or putative 
pilus-like genes were identified (Maldarelli, De Masi, von Rosenvinge, Carter, & 
Donnenberg, 2014). Recently, it has been demonstrated in historical epidemic strains 630 
and R20291 that the type IV pilus contributes to biofilm formation, especially in the strain 
R20291. Additionally, it was also reported that this strain is capable of motility in a type IV 
pilus-depended manner (Purcell, McKee, Bordeleau, Burrus, & Tamayo, 2015).  
 
1.3.5. Clostridium difficile adhesins 
 
C. difficile has been shown to be able to adhere to various cell lines. For example, HT-29-
MTX cells, enterocyte-like Caco-2 cells, Hep-2 cells, Vero and HeLa cells (T Karjalainen et 
al., 1994; Naaber, Lehto, Salminen, & Mikelsaar, 1996; O’farrely, Baird, Drudy, Fenelon, & 
O’Donoghue, 2001). Equally, C. difficile attaches to a plethora of extracellular matrix 
proteins (ECM) in vitro: fibronectin, fibrinogen, vitronectin, and type -I, -III, -IV and -V 
collagens (Cerquetti, Serafino, Sebastianelli, & Mastrantonio, 2002). The broad picture of C. 
difficile adhesion shows that the host-bacterium attachment requires adhesins from a bacterial 
origin that in general terms are proteins present on the cell surface. A plethora of adhesins 
has been characterized: fibronectin binding proteins, the heat shock protein GroEL, cell wall 
proteins (Cwp), flagella, fimbriae, etc. However, their function in the pathogenesis of CDI is 
still not fully understood. In the next sections, we will focus on the Cwp protein family.  
 
1.3.6. Cwp proteins 
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The Cwp proteins are a group of closely related paralogous surface-associated proteins that 
are composed of 29 members characterized by the presence of a conserved binding domain 
(Pfam 04122) that attaches the proteins to the bacterial cell-wall by PSII molecules (R. P. 
Fagan et al., 2011; Willing et al., 2015). Almost half of the Cwp proteins are found within 
the “clostridial wall (cwp) gene cluster.” This cluster has 18 open reading frames (ORFs) 
(Figure 4). The rest of the Cwp proteins are scattered throughout the bacterial chromosome. 
Different studies have shown that some of these proteins (like the protein CwpV) are secreted 
by the dedicated secretion system, SecA2 (K. E. Dingle et al., 2013). It is possible that other 
members of the Cwp family can use the same secretion system to be transported to the cell-
wall. The cwp genes that are located inside the cwp cluster, like the cysteine protease Cwp84, 
presents high variability among C. difficile strains (Tuomo Karjalainen, Saumier, Barc, 
Delmée, & Collignon, 2002; Savariau-Lacomme, Lebarbier, Karjalainen, Collignon, & 
Janoir, 2003) This variability is also true for proteins like SlpA, Cwp66, and SecA2 where 
their coding sequences are shown to somehow be variable (regions prone to genetic 
exchanges by homologous recombination (K. E. Dingle et al., 2013)). In this order of ideas, 
the genetic variability present in Cwp surface proteins emerges from the immunological 
pressure from the host and contributes to its avoidance. Several of the Cwp proteins are 
immunogenic in patients (Drudy et al., 2004; Pechine, 2005; Pechine, Janoir, & Collignon, 
2005; Wright, Drudy, Kyne, Brown, & Fairweather, 2008). Therefore, they could play an 
essential function in the colonization process and pathogenesis of the disease. 
 
 
 
 
Figure 4. Genetic organization around the cwp cluster in the strain CD630. The C. 
difficile S-layer is encoded by the slpA gene, positioned within the 36.6-kb cell-wall 
protein (cwp) gene cluster. Image modified from (Dingle et al., 2013) 
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1.3.6.1. Cwp84 cysteine protease 
 
The cysteine protease Cwp84 coding sequence is present in the cwp cluster and is transcribed 
using its promoter (Savariau-Lacomme et al., 2003). Cwp84 is found localized embedded in 
the bacterial S-layer and requires the processing of its pro-peptide signal by another cell-wall 
associated cysteine protease, Cwp13 (which is also present in the cwp gene cluster and can 
be found incorporated into the S-layer) (de la Riva, Willing, Tate, & Fairweather, 2011). 
Once Cwp84 is fully processed, its complete conformation is responsible for the proteolytic 
cleavage of the SlpA precursor. Mutants of the Cwp84 proteins present retention of proteins 
of the cell-wall. This mutation results in a colony phenotype in which the colony formation 
is not cohesive and formless (de la Riva et al., 2011). Other studies also indicate that possibly 
the function of Cwp84 in the disease pathogenesis is not essential due to results showing that 
a mutant for the protease is as virulent as the wild-type strain in a hamster model (Kirby et 
al., 2009). 
 
1.3.6.2. Cwp66 adhesin 
 
Cwp66 was the first adhesin to be identified in the class Clostridia (Waligora et al., 2001). 
The cwp66 gene is found inside the cwp cluster and synthesizes a protein overproduced at 
the surface of the cell just after a heat-shock. It was proven to mediate adhesion to the cell 
line Vero (Waligora et al., 2001). As other proteins from the same cluster, Cwp66 contains 
two domains, one of which is highly variable. Both domains can be detected by antibodies 
in bacterial surface extracts. The function of Cwp66 in cell adherence was demonstrated by 
utilizing the same antibodies in attaching inhibition studies with the purified domains. 
However, no mutant for the protein has been evaluated yet and its role in the pathogenesis of 
the disease is unknown.  
 
1.3.6.3. CwpV protein 
 
Of all the members of the Cwp family, CwpV is the largest protein. Its coding sequence is 
not present in the cwp cluster. The variable region of CwpV is located toward the C-terminal 
end; this domain starts with a serine-glycine enriched flexible linker which is followed by 
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several repetitions, whose sequence and number change depending on the C. difficile strain 
(Figure 5). The N-terminal domain possesses the cell-wall anchoring activity via three CWB2 
motifs that recognize PSII molecules embedded in the bacterial cell-wall (Willing et al., 
2015). Like SlpA, CwpV protein undergoes maturation into two subunits that are re-
associated in a non-covalent manner to form a heterodimeric complex that attaches to the 
bacterial cell-wall (Robert P Fagan & Fairweather, 2014; Reynolds, Emerson, de la Riva, 
Fagan, & Fairweather, 2011a). Interestingly, and different from SlpA, CwpV post-
translational cleavage is mediated by intramolecular auto-proteolysis (this phenomenon is 
also present in Cwp13) (Dembek, Reynolds, & Fairweather, 2012). CwpV is exported to the 
cell-wall through the secA2-secretion system (Robert P Fagan & Fairweather, 2011). CwpV 
is a major component of C. difficile cell-wall, representing about 13% of the whole surface 
layer proteins (Reynolds et al., 2011a).  
 
In a controlled laboratory environment, only 5% of the viable cells of the entire bacterial 
population express the protein. The phase variation of CwpV is regulated by DNA inversion, 
a mechanism of transcriptional termination by the creation of a stem-loop structure followed 
by a poly-U tract, which promotes transcriptional termination, in the OFF (non-
transcriptional) position (Emerson et al., 2009). The C-terminal domain of CwpV presents 
auto-aggregative characteristics (Reynolds et al., 2011a), but its link with biofilm formation 
(and possible role in gut colonization) is still unknown. Future analyses are necessary to 
assess the biological role of CwpV. More information about the role of CwpV in 
bacteriophage infection can be found in the section 1.9.5.  
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1.4. Bacteriophages 
 
Bacteriophages (phages) are parasites that infect bacteria and are presently viewed as the 
most abundant and diverse biological entities on Earth. Their vastness is not only quantitative 
(they surpass bacterial organisms by a ratio of 1:10), their ecology, morphology, infection 
strategies and other qualitative characteristics also represent relevant and exciting study 
fields (Brüssow & Hendrix, 2002). For example, it has been stated that only in the seas phages 
infect bacteria sufficiently to produce more than 1011 kilograms of carbon per day from 
natural populations, thus affecting the ecology of the planet directly (Suttle, 2007).  
 
Phages have the capacity of killing their bacterial host. But also their genomes can transfer 
to the bacterial genome toxins and complementary virulence factors that can modify the host 
and affect human bacterial pathogens (Fortier & Sekulovic, 2013). In an identical manner, 
phage diversity contributes to bacterial diversity directly. Phages can function as genetic 
vehicles for transduction of various genes, for example, antibiotics resistance genes among 
different populations (Figure 6) (Grose & Casjens, 2014). In all ecosystems on the planet, a 
large array of phages and hosts are tangled in an endless co-evolution cycle, in which 
emerging phage resistant hosts continuously preserve bacterial taxa, but on the other hand, 
 
Figure 5. Visual representation of natural CwpV types. The CwpV type II from the 
strain R20291 was used in this study. Color code: Black, signal peptide; grey, cell-wall 
anchoring domain (PF04122); white, non-described function; pink, serine-glycine-rich 
region; blue, type I repetition; orange, type II repetition, green, type III repetition; red, 
type IV repetition; purple, type V repetitions. Image modified from (Sekulovic et al., 
2015a). 
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counter-resistant phages attack these new bacterial groups. Widely speaking, phages and 
phage resistance mechanism have an important function in the control of bacteria in most 
habitats on the planet.  
 
 
1.5. Bacteriophage taxonomy 
 
At present day, bacterial viruses include at least 14 officially accepted families, and 
approximately 5500 phages have been isolated and investigated by electron microscopy (H.-
W. Ackermann, 2007; Hans-W. Ackermann, 2009). The categorization of these phages has 
been essential in understanding the biodiversity and their ecological role. In the same manner, 
it has directed the creation of a phylogenetic tree of phages. Different from the rest of life, 
 
Figure 6. Illustration of the lytic and lysogenic life cycles of phage λ. Taken from 
(Campbell, 2003). 
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viruses are polyphyletic and do not possess conserved genes among them (for example 
ribosomal RNA genes) that are used in phylogenetic analyses for classification purposes. In 
this order of ideas, phage taxonomy can be considered as a quite complicated task, also 
adding up the fact that phages have the capability of acquiring, transmitting, and mixing 
genetic material in a fast way. The International Committee on Taxonomy of Viruses (ICTV) 
has proposed a classification system in which it is taking into account the nature of the nucleic 
acids, nucleotide sequences and the viral structure of the phages (van Regenmortel, Mayo, 
Fauquet, & Maniloff, 2000).  
 
From the current taxonomy, we know that most phages belong to the order Caudovirales and 
this group is divided among three main families; Myoviridae, Podoviridae, and Siphoviridae. 
From these families, Podoviridae contains around 60% of all known phages (IUMS, 2016). 
In a similar manner, the different phages have different morphologic features. However, they 
can conserve certain common structures. In fact, all phages contain their genetic material 
(DNA or RNA) inside a capsid that is made of protein or lipoproteins. Nevertheless, the main 
structural characteristic of the phage from the order Caudovirales is the presence of a “tail” 
that helps in the recognition, attachment, and injection of the DNA into the cytosolic space. 
It is important to remark that there are differences among the tails of the three families. The 
Myoviridae tail is relatively short but rigid and contractile, whereas the Siphoviridae tail is 
long and non-contractile. The phages of the Podoviridae family have a very short tail but 
non-contractile (H.-W. Ackermann, 2007; Hans-W. Ackermann, 2009; Grath & Sinderen, 
2007; Hyman & Abedon, 2012). We show examples of the family structures in Figure 7. 
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1.6. Bacteriophage replication cycle 
 
Despite the exceptional biodiversity that phages can bear, the mechanisms responsible for 
viral replication are conserved among the different families. Phages are forced to overtake 
the cellular machinery and metabolic processes to complete their infection cycle and achieve 
their replication (Grath & Sinderen, 2007). 
 
1.6.1. Host receptors and bacteriophage adsorption 
 
Adsorption is the first step of the infection process; the attachment of the phage to the cell 
surface. This initial recognition is made at first in a reversible manner by the interaction of 
the virion with a receptor on the surface of the bacterium. In phages with tail structures, this 
reversible interaction is made by the utilization of proteins localized in the distal part of the 
tail. Then the adsorption of the phage on the host surface becomes irreversible by the 
 
Figure 7. Diversity in bacteriophage families: Morphologies, genome natures, and 
comparative genome sizes. Bacteriophages are arranged in order of decreasing genome 
sizes. Blue coloration indicates capsids, red indicates tails, and yellow refers to lipids. 
Tailed bacteriophages are members of viral order Caudovirales. Image taken from 
(Hyman & Abedon, 2012). 
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interaction between the receptor binding proteins (RBP) of the phage and the bacterial 
receptors on the surface (Silva, Storms, & Sauvageau, 2016; Weinbauer, 2004). Different 
surface molecules are recognized to play the role of a receptor in the adsorption process, for 
example, the polysaccharides, lipopolysaccharides (LPS), teichoic acids, lipoteichoic acids 
(LTAs), and glycoproteins function as entry ports to the cell (Grath & Sinderen, 2007; Silva 
et al., 2016). In particular cases, phages can recognize the capsule, conjugation pilus, and 
flagella as means of attachment to the bacterial surface (Geoffrey William Hanlon, 2007). 
This natural diversity in receptors and structures of both sides reflects the evolutionary 
relationship between phages and bacteria.  
 
However, just one receptor may not be involved in the attachment and adsorption; it is 
possible to find in nature a two-host receptor entry mechanism. Even the proteins and 
molecules involved in the reversible part of the adsorption could be different than the proteins 
and receptor involved in the irreversible part of the adsorption. For example, the phage T4 
contains long tail fibers that interact with E. coli membrane, and this interaction is responsible 
for the first reversible binding. The short fibers of the virions interact with the heptose 
fraction of the LPS of the host and account for its irreversible binding (Silva et al., 2016). In 
the same manner for the Gram-positive bacterium Bacillus subtilis, its phage SPP1 utilizes 
the glycosylated cell-wall lipoteichoic acids (LTA) for a primarily reversible binding, 
followed by the interaction between the phage protein gp21 and the cell membrane protein 
YueB that determines the irreversible adsorption. It is hypothesized that the ability of a phage 
to engage an irreversible adsorption to molecules that are more expressed or commonly found 
on the cell-wall can increase the probability of finding the cellular receptor that determines 
its irreversible adsorption (Chatterjee & Rothenberg, 2012). 
 
1.6.2. DNA injection  
 
Right after the adsorption, the downstream step of phage infection is the injection of the viral 
DNA into the host cytoplasm. This process can be done in different ways, depending on the 
structural morphology of the phage that is infecting. For example, the phages from the 
Myoviridae family contract a rigid protein sheath that is capable of piercing the bacterial 
membrane and force the viral DNA to be released from the capsid and be translocated to the 
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cytosol of the bacterium. In some cases, hydrolytic enzymes can be present in the virion and 
degrade the cell wall polymers and facilitate viral DNA entry (González-Huici, Salas, & 
Hermoso, 2004; Geoffrey William Hanlon, 2007). However, although phage adsorption and 
DNA injection have been studied since Hershey–Chase experiments in 1952, these particular 
steps of the phage replication cycle are still poorly understood.  
 
In general terms, for DNA liberation from the capsid, a signal activation must take place from 
the host receptor to the phage virion structure, which triggers the capsid opening and future 
DNA injection. Still, each phage has its unique mechanism and strategy for DNA injection. 
For the coliphage λ which infects E. coli, it is hypothesized that the viral DNA enters just by 
diffusion (Filali Maltouf & Labedan, 1985; González-Huici et al., 2004). Phage T4 pierces 
the cell membrane using its contractile tail and a cell-puncturing apparatus in the baseplate 
of the virions (Hans-W. Ackermann, 2009). For phage T5, the injection process has two 
steps: 8% of the viral DNA is translocated to the cytoplasm. From there, the proteins A1 and 
A2 are synthesized from the region that was transferred; these two proteins are necessary for 
the translocation of the rest of the viral genomes. It is thought that DNA binding domains in 
the proteins A1 and A2 pull the DNA into the cell (Letellier, Boulanger, de Frutos, & Jacquot, 
2003). In the Gram-positive bacterium, B. subtilis, the phage Ø29, that has a non-contractile 
tail, also presents a two-step process. In the first step, DNA is injected into the cytoplasm 
possibly by the differential of pressure created from the virion to the cell. Thus, synthesis of 
early operons is activated. The second step is initiated when one of the early viral proteins, 
p17, participates in the molecular complex that initiates the translocation of the rest of the 
genome inside of the bacterium (González-Huici et al., 2004).  
 
1.6.3. Replication cycle 
 
In most known phages, there are two main ways of replication: the lytic cycle and the 
lysogenic cycle. Phages that use the lytic cycle are called virulent or strictly lytic, whereas 
phages that have the capability of changing their replication from the lytic to the lysogenic 
cycle are called temperate phages.  
 
1.6.3.1. Lytic cycle 
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During the lytic cycle, phages replicate their genome producing a plethora of significant 
changes in the host bacterium. Ultimately, these changes cause the bacterium to stop most its 
cellular processes and all the cell machinery is deviated to assure the production of new viral 
particles. Just after the injection of the viral DNA into the cytosol of the bacterium, the 
bacterial RNA polymerase is recruited to transcribe early genes that are implicated in the 
transcription, gene regulation, DNA replication, and recombination. Afterward, late genes 
are transcribed, allowing the synthesis of structural proteins (capsid, tail, RBP, and so forth). 
In parallel, the bacterial DNA polymerase is recruited, permitting the replication of the viral 
genome. Altogether, viral structural proteins and DNA are assembled, forming new infective 
virions. The last step of the process is the liberation of the viral offspring from the 
intracellular space to the environment. This cellular lysis is possible by the activity of two 
main enzymes, the endolysin, and the holin. On one hand, the endolysins are hydrolytic 
enzymes that degrade the peptidoglycan cleaving different types of bonds at the interior of 
the polymeric structure. On the other hand, the holins are hydrophobic proteins that have the 
function of inserting themselves in the cytoplasmic membrane (at a precise moment of the 
lytic cycle) and produce pores that ultimately will allow the endolysins to reach the 
peptidoglycan and cleave it. After the cellular lysis, virions are released into the environment 
ready to find a new cell and start again the lytic cycle (Borysowski, Weber-Dabrowska, & 
Górski, 2006; Kutter & Sulakvelidze, 2005; Weinbauer, 2004). 
 
1.6.3.2. Lysogenic cycle 
 
The particularity of temperate phages is their capability to alternate between the lytic and 
lysogenic replication cycles. After the infection and the translocation of the viral DNA into 
the host cytosol, a molecular decision is taken toward one of the replication cycles. The lytic 
cycle was described above. On the contrary, if the phage “decides” to take the lysogenic 
cycle, the necessary genes for the lytic cycle are repressed, and the phage genome is 
integrated into the bacterial chromosome (Hans-W. Ackermann, 2009; Grath & Sinderen, 
2007). Already part of the host genome, every single division of the bacterium signifies the 
replication of the bacterial chromosome along with the replication of the viral genome. 
Bacteria with an inserted phage genome are called lysogens, and the phage takes the name 
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of prophage. The decision regarding the infection cycle is made early after the infection, and 
this one is firmly affected by the condition of the intracellular environment inside the 
bacterium. In fact, DNA damage and unfavorable environmental conditions are known to 
bias the phage to take the lytic cycle (Kutter & Sulakvelidze, 2005). In that way, when a 
phage opts for the lysogenic cycle, some repressors are transcribed and translated to block 
the expression of the genes implicated in the lytic cycle (for example, CI, CII and CIII in the 
coliphage λ) (Anderson & Yang, 2008; Babic & Little, 2007). However, the decision of 
taking the lysogenic cycle is complex, and many of the mechanisms are still not understood. 
The enzyme integrase is also expressed and is responsible for the viral genome integration 
into the bacterial chromosome. Phages are remarkably stable once inserted into their host 
genome. However, under the right condition, it is possible to reintroduce the phage to the 
lytic cycle and release themselves from the host (Babic & Little, 2007; Little, 1999). Certain 
intracellular conditions of the host can also cause the induction of the prophage and the 
initiation of the lytic cycle. Stress factors like U.V light, temperature changes, the presence 
of different compounds (H2O2, antibiotics) are well known for triggering an SOS response 
of the lysogen. In E. coli, when the bacterial protein RecA is activated, its activity causes the 
autocleavage of the repressor of the SOS genes, LexA. The inactivation of this repressor 
permits then the transcription and future translation of the SOS genes, those implicated in 
DNA damage reparation. Equally, activation of the RecA protein leads to the proteolytic 
cleavage of the CI repressor, that maintains the phage in his prophage state and regulates 
another repressor of the lysogenic cycle. The relaxation of the expression of the repressors 
CI, CII, and CIII, promotes the augmentation of the expression of the protein Cro, which can 
activate the transcription of some genes of the lytic cycle and repress at the same time the 
genes from the lysogenic cycle (Court, Oppenheim, & Adhya, 2007).  
 
1.7. Bacteriophages of Clostridium difficile  
 
To date, all members of the sequenced C. difficile phages that have been described in the 
scientific literature are temperate phages of the Caudovirales order (phages with tail) and are 
classified into the Myoviridae or Siphoviridae families (where the majority of the diversity 
is found in the Myoviridae family and the Siphoviridae family having just a few members) 
(Hargreaves & Clokie, 2014, 2015; Sekulovic, Garneau, Néron, & Fortier, 2014). The 
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myoviruses can be sorted into three discrete morphological clades based on the capsid 
diameter and tail lengths. Small Myoviridae phages with capsid diameters of 40–60 nm and 
tail lengths of 105–110 nm. Intermediate sized with capsid diameters between ~60–70 nm 
and tail lengths of 110–130 nm. And finally, long-tailed with capsid diameter between ~60 
to ~70 nm and tail lengths between 150–260 nm. All known C. difficile phages follow a 
lysogenic life cycle, their genome is characterized by the presence of predicted integrase 
genes, and their genome sizes range from ~31 to ~131 kbps with a GC content of 28.4% to 
30.8%. The C. difficile phages utilized in this study are presented in Table 1. 
 
1.8. Lactococcus lactis and its bacteriophages 
 
Lactococcus lactis is a microorganism that has been tamed and utilized for millennia in dairy 
fermentations. L. lactis abides in niches close to animal and plant surfaces, and is also found 
in the gastric cavities. However, L. lactis industrial strains used in cheese buttermilk, and 
sour cream fermentation have the ability to grow faster and rapidly produce lactic acid in 
milk. Although it has evident industrial interest, L. lactis has become an important research 
model among other Gram-positive bacteria for subjects such as metabolism, physiology, 
genetics, and molecular biology. However, at the same time, the investment in fundamental 
research has stimulated potential new applications such as heterologous metabolite/protein 
synthesis, massive culture protection, and oral vaccines (Bolotin et al., 2001). 
 
Lactococcal phages are ubiquitous in nature where the host is present, but also in the dairy 
environment. The virulent nature of all lactococcal phages, their biodiversity and its adverse 
effect in large-scale fermentations, promoted their study around the world. Hence, several 
lactococcal phages have been isolated and characterized. In fact, only coliphages have been 
more studied than phages from the dairy industry (H. W. Ackermann, 2001). All phages from 
L. lactis known to date present a double-stranded DNA and noncontractile tail structure and 
fall within the Caudovirales order. Lactococcal phages are primarily classified in the 
Siphoviridae family and a few members are in the Podoviridae family. Historically, 
lactococcal viruses were classified using virion morphology and DNA homology index. This 
classification sorted dairy pages in three different main groups: the 936, c2, and P335 phages. 
As research techniques advanced, investigators continued with this three-group classification 
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but adapting multiplex PCR to rapidly assign new phages to those three groups (Deveau, 
Labrie, Chopin, & Moineau, 2006; S. Labrie & Moineau, 2000). The fast growth of L. lactis 
cultures permits the easy amplification and replication of phages in solid and liquid broth. 
The well-known secretion system of L. lactis also allows the intracellular expression and 
secretion of heterologous proteins, making this bacterium a useful model microorganism. 
Equally, the absence of a lysogenic cycle among its phages greatly simplifies the study of 
antiphage systems.  
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Table 1. C. difficile phage morphology, host, and origin of the viral particles used in this 
study. Virions were observed by TEM after negative staining with uranyl acetate. Phages 
are not displayed on the same scale. The black bars represent 100 nm. Phages Φ38-2 and 
ΦCD52 are not shown. When available, the Genbank accession number is indicated. NS, 
no-sequence. Pictures are taken from (Meessen-Pinard, 2010) and (Sekulovic et al., 2014). 
ΦCD111 ΦCD146 ΦCD481-1 ΦCD481-2 
  
   
Natural host: CD111 
Origin: Human 
Family: Siphoviridae 
LN681535 
Natural host: CD146 
Origin: Human 
Family: Siphoviridae 
LN681536 
Natural host:CD481 
Origin: Horse 
Family: Myoviridae 
LN681538 
Natural host:CD481 
Origin: Horse 
Family: Myoviridae 
NS 
ΦCD505 ΦCD506 ΦCD508  
   
 
Natural host:CD505 
Origin: Dog 
Family: Myoviridae 
LN681539 
Natural host: CD506 
Origin: Dog 
Family: Myoviridae 
LN681540 
Natural host:CD508 
Origin: Dog 
Family: Myoviridae 
NS 
  
ΦMMP01 ΦMMP02 ΦMMP03 ΦMMP04 
    
Natural host: CD19 
Origin: Human 
Family: Myoviridae 
LN681541 
Natural host: CD343 
Origin: Human 
Family: Myoviridae 
NC_019421 
Natural host:CD368 
Origin: Human 
Family: Myoviridae 
LN681542 
Natural host: CD380 
Origin: Human 
Family: Myoviridae  
NC_019422 
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1.9. Antiphage systems: Infinite bacterial war 
 
Bacteria and phages are tangled in a constant war for survival, and these interactions lead to 
advantageous or damaging effects in the species that are interacting. Both cannot be 
described and studied in isolation. As traditional ecological models show, a predatory-prey 
interaction (parasite-host) stimulates the continuous adaptation of the involved species to 
keep their fitness constant. Leigh Van Vales proposed in his “Red Queen” hypothesis that 
between two species, an advantageous adaptation of one species declines the fitness of the 
other. This fundamental evolutionary existence leads to a constant cycle of adaptation and 
counter-adaptation that could act as a strong force in evolution. As preys of viruses, bacteria 
have evolved a plethora of antiphage mechanisms to survive the constant pressure for 
survival. Phage resistance is a decisive phenomenon present in almost all ecological niches 
which can take different kinds of molecular strategies at various levels of phage infection. 
Below, I describe the most common antiphage systems in bacteria and how phages can 
overturn these mechanisms. 
 
1.9.1. Restriction–modification systems  
 
Restriction–modification (R–M) systems are widespread among different taxa of archaea and 
bacteria. Their functions are mediated by numerous heterogeneous proteins that have been 
sorted into at least four different groups (type I–type IV) (S. J. Labrie, Samson, & Moineau, 
2010; Samson, Magadán, Sabri, & Moineau, 2013). The R-M systems are vital components 
of the prokaryotic arsenal against genetic parasites. When unmethylated, phage DNA enters 
the cytoplasm of a cell bearing an R–M system, the restriction endonuclease cleaves the 
foreign DNA at specific places of its sequence (restriction sites) (Vasu & Nagaraja, 2013). 
To evade the restriction activity on its own DNA, the host uses a methyltransferase. The host 
blocks the endonuclease by inserting methyl groups on the restriction sites of its DNA. Phage 
DNA can be also methylated. When the methylation occurs on viral DNA, the new viral 
particles become resistant to the cognate restriction enzyme and easily infect adjacent 
bacteria containing the same R–M system (Samson et al., 2013; Vasu & Nagaraja, 2013) 
 
1.9.2. The CRISPR–Cas system 
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One of the most important anti-phage systems regarding biotechnological applications is the 
CRISPR–Cas system. The function of clustered regularly interspaced short palindromic 
repeats (CRISPRs) and the CRISPR-associated (cas) genes on phage infection and 
replication have been extensively described in the last decade (Boudry et al., 2015; Rath, 
Amlinger, Rath, & Lundgren, 2015). Phylogenetic analysis has shown that they are present 
in several bacterial, archaeal, and even viral genomes (S. J. Labrie et al., 2010). The locus is 
a composition of short repeated sequences separated by non-repetitive spacers. CRISPRs can 
be found in chromosomal DNA, plasmids, and phage DNA. The spacers are adapted from 
exogenous sequences from viruses and plasmids, giving the idea that the system could have 
emerged as a bacterial immunity system (Rath et al., 2015). The acquisition of news spacers 
renders the organism resistant to viruses containing the target sequences. When a phage-
sensitive strain carrying a functional CRISPR-Cas system is infected by a virulent phage, 
natural phage-resistant mutants will eventually emerge. These mutants are known to have 
acquired at least one novel repeat-spacer unit at the 5′ end of the repeat-spacer region of a 
CRISPR locus (Rath et al., 2015). The newly added spacer is close or identical to a sequence 
called the proto-spacer which is found in the genome of the infecting virulent phage or 
plasmid. CRISPR activation involves a set of cas genes that are normally located near the 
CRISPR sequences. The cas genes encode proteins that are necessary for the recognition of 
invading DNA. For further details on the CRISPR–Cas system in C. difficile see Boudry et 
al., 2015 (Boudry et al., 2015). 
 
1.9.3. Blocking of bacteriophage adsorption  
 
Adsorption to bacterial receptors is the first step of phage infection and possibly one of the 
most complex events, as phages must sense a particular host cellular factor. The ability to 
infect a host is lost when the phages cannot interact with the receptors. In normal conditions, 
phages encounter an enormous biodiversity in terms of the chemical composition of host 
membranes and cell-walls. Moreover, bacteria have developed a plethora of mechanisms to 
block phage adsorption. Adsorption resistance can be classified into three different 
 
 
28 
28 
categories: the blockage of receptors, extracellular matrix production and synthesis of 
competitive inhibitors (S. J. Labrie et al., 2010) (Figure 8). 
 
 
1.9.3.1. Blockage of receptors 
 
This first category comprises all the cases where the bacteria hide the receptors to make them 
not accessible to the receptor binding proteins from the phage. A representation of this could 
be Staphylococcus aureus which produces a cell-wall attached virulence factor, protein A 
 
Figure 8. Strategies used by bacteria to block bacteriophage adsorption. A. 
Bacteriophage adsorption to the bacterial cell-wall occurs through recognition of a 
bacteriophage receptor on the surface. Bacteria can resist the attack by altering these 
surface receptors (1); bacteriophages can adapt to recognize these new receptors (2). 
Bacteria can also produce proteins that cover the bacteriophage receptor (3). B. 
Bacteriophage adsorption can be impeded by the production of exopolysaccharide (EPS), 
nevertheless bacteriophages can overcome the EPS coat by producing a polysaccharide 
lyase or a polysaccharide hydrolase to cleave the layers. C. Bacteriophages evolved to 
precisely identify polysaccharides. However, bacteria can modify those molecules and 
avoid infection.  
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(Foster, 2005). It has been proven that phage adsorption is reduced when the host synthesizes 
the protein A. This shows that the receptor of the phage is masked by this protein (Nordström 
& Forsgren, 1974) (Figure 8A). A second case relates to the phage T5, that replicates in E. 
coli, and encodes a lipoprotein called Llp that can block its receptor, ferrochrome-iron 
receptor (FhuA). Llp is synthesized during the first part of the infection process, therefore 
preventing secondary infections by other phages. Equally, Llp protects newly released T5 
virions from inactivation by binding to soluble receptors that are released from lysed cells. 
(Pedruzzi, Rosenbusch, & Locher, 1998).  
 
1.9.3.2. Extracellular matrix production 
 
The second category also involves masking of the receptor but through the synthesis of 
exopolysaccharides. The production of extracellular polymers can help in the bacterial 
survival in diverse environments assisting the bacteria against difficult niche conditions and 
even helping as a physical wall between the phages and the cellular receptor. However, some 
of these phages adapted to recognize these extracellular polymers (Figure 8C). Some of them 
even evolved the capability to degrade them (Linhardt, Galliher, & Cooney, 1986; 
Stummeyer et al., 2006; Ian W. Sutherland, 1999; Ian W Sutherland, Hughes, Skillman, & 
Tait, 2004; I W Sutherland, 1995) (Figure 8B). The enzymes used by the phages for this 
activity are found either linked to the structure of the viral particle (attached to the receptor 
binding protein) or also free enzymes released from the intracellular space when bacteria are 
lysed (I W Sutherland, 1995). Pseudomonas spp. and Azotobacter spp. produce alginates, 
that are a type of exopolysaccharide. In alginate-producing Azotobacter spp. bacteria, it was 
detected an augmentation in  phage resistance (Hammad, 1998; G. W. Hanlon, Denyer, Olliff, 
& Ibrahim, 2001). Nevertheless, phage F116, which infects Pseudomonas spp., synthesizes 
an alginate lyase, that can assist in the diffusion of the phage through the polysaccharide 
matrix (G. W. Hanlon et al., 2001). 
 
1.9.3.3. Synthesis of competitive inhibitors 
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The third category includes the competition that some molecules can impose to phages that 
attach to the same receptor (Figure 8A). In E. coli, the protein FhuA is an iron transporter 
and equally the receptor for phages such as T1, T5, and Φ80. Micromicin J25 is an 
antimicrobial compound that can use FhuA as an entry port to the bacterium. This molecule 
can compete with phage T5 for attaching to the FhuA (Destoumieux-Garzón et al., 2005). 
Micromicin J25 is synthesized under harsh environmental conditions and has an activity 
mainly in niche competition by restraining the growth of closely related strains, permitting 
the bacterium to escape from phage infection (Labrie et al., 2010). 
 
1.9.4. Blocking bacteriophage DNA injection 
 
1.9.4.1. Superinfection exclusion (Sie) systems  
 
Superinfection exclusion is the phenomenon of a resident virus that restricts a secondary 
virus infection. These Sie systems are composed of molecules that interrupt the translocation 
of phage DNA into the bacterial cytoplasm, thus giving immunity against superinfecting 
phages. These molecules are predicted to be present at the cellular membrane or anchored to 
cell-wall components (Beperet et al., 2014). Usually, the genes that encode such proteins are 
present in prophages. This indication suggests that possibly the Sie systems are a way of 
interaction between prophages and phage from secondary infection in a single cell. Several 
Sie systems have been identified, but only a few of them have been characterized. 
 
1.9.4.2. Gram-negative bacteria Sie systems 
 
E. coli has the most characterized Sie systems, imm and sp. These two proteins can hasty 
block the DNA injection of the virulent phage T4 into the bacterium, avoiding future viral 
replication (Figure 9). Imm and Sp can act independently and have different action 
mechanisms. Imm prevents the translocation of phage DNA into bacterial cytosol by altering 
the structure of the injection port. Imm has two transmembrane domains and is predicted to 
be anchored to the membrane. However, Imm cannot protect by itself, and it is possibly 
accompanied by another membrane protein that activates its function (Lu, Stierhof, & 
Henning, 1993). The protein Sp inhibits the enzymatic activity of the T4 lysozyme, 
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preventing peptidoglycan degradation and entry of the viral DNA. The T4 lysozyme is 
present at the most distal part of the phage tail and pierces holes in the bacterial cell, which 
facilitates the injection of the phage DNA (Lu & Henning, 1994; Moak & Molineux, 2000). 
Also in E. coli, it has been proven that the phage HK97, which encodes the moron element 
gp15 (a moron element is an autonomously regulated DNA sequence inserted between a pair 
of genes that are usually adjacent in a phage genome) is responsible for the resistance to 
infection by other HK97 phages (independent of repressor immunity) and HK75 phages 
(Cumby, Edwards, Davidson, & Maxwell, 2012). Another example is the Sie system encoded 
by the phage φX174. This system operates in the bacterial membrane (changing a surface 
element that is not discovered yet) and also modifies the function of the host essential proteins 
for the conversion of the single stranded viral DNA to double-stranded DNA ( a replicative 
form of the phage) (Hutchison & Sinsheimer, 1971).  
 
1.9.4.3 Gram-positive bacteria Sie systems 
 
 
Figure 9. Blocking bacteriophage DNA translocation into the bacterial cell by a 
bacteriophage-encoded Superinfection exclusion (Sie) system. A. Bacteriophage T4 
DNA translocation in Escherichia coli. The peptidogycan layer is degraded, and an inner-
membrane protein is involved in the translocation of the DNA into the cytoplasm. B. 
Bacteriophage T4 synthetizes the protein Imm, which impedes the injection of 
bacteriophage DNA into the bacterial cytosol, therefore preventing infection by other T4-
like bacteriophages. C. The protein Sp blocks cleavage of the peptidoglycan polymer, 
trapping the viral DNA between the peptidoglycan layer and the outer membrane. Image 
taken from (Labrie et al., 2010). 
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Gram-negative bacteria have been very relevant research models of study. It is necessary to 
fill the gap regarding other organisms and promote the research in fields where phages and 
Gram-positive bacteria converge. There are few examples of this kind of DNA blocking 
systems detected in Gram-positive bacteria. The majority was identified in L. lactis strains 
(Akçelik, 1998; Garvey, Hill, & Fitzgerald, 1996). One of the most characterized mechanism 
is the Sie2009, which was detected in the genome of the integrated lactococcal phage 
Tuc2009 and later found in other prophages integrated into the genomes of several L. lactis 
strains. The second most diverse group of lactococcal phages is the group called P335, and 
Sie2009 from these phages renders the bacteria resistant to an unrelated phage group called 
936. Lactococcal Sie systems are predicted to be present in the cellular membrane, and they 
can activate phage resistance by interrupting the translocation of phage DNA into the 
cytoplasm (Mahony, McGrath, Fitzgerald, & van Sinderen, 2008; McGrath, Fitzgerald, & 
van Sinderen, 2002). Other Sie-like systems have been detected in Streptococcus 
thermophilus (Akçelik, 1998; Garvey et al., 1996). Phage TP‐J34 synthesizes a 142-amino 
acid lipoprotein (LTP) that stops the injection of viral DNA into the bacteria. Amazingly, 
this mechanism gives resistance also to some lactococcal phages when transferred into the 
heterologous host L. lactis (Sun, Göhler, Heller, & Neve, 2006b). Finally, our lab has recently 
shown that the C. difficile membrane protein CwpV could protect bacteria from phage 
infection in a similar manner to Sie systems (further details are showed in the section 1.9.5 
and 3.0) 
 
1.9.5. CwpV protects against bacteriophage infection in C. difficile   
 
In a first transcriptomic study using C. difficile R20291, our laboratory team isolated a 
lysogen containing the episomal prophage φCD38-2. In this lysogen, the cwpV gene was 
found upregulated by about 20-fold (Sekulovic & Fortier, 2015). Although it is unknown the 
way φCD38-2 affects CwpV synthesis, the latter observation led us to investigate cwpV 
expression.  
 
The cwpV gene encodes a protein that is present in the bacterial cell wall of all C. difficile 
strains known to date (more information on CwpV is detailed in the section 1.3.6.3). The 
function of the protein remains unclear; however, some experimental studies suggests that 
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CwpV has a role in bacterial aggregation, which could ultimately impact gut colonization 
(Reynolds et al., 2011b). Interestingly, cwpV expression presents a bacterial phenomenon 
called phase variation. In general terms, only a part of the bacterial population synthesizes 
and expresses the protein (Emerson et al., 2009). The biological role of phase-variable 
mechanisms is not well understood, and numerous hypotheses have been proposed. Notably, 
one hypothesis suggests that when CwpV is expressed on the cell surface, it could interfere 
with phage infection (Reynolds et al., 2011b). Aligned with this hypothesis, several phage 
receptors, and infection resistance mechanisms are under a phase-variable regulation 
(Hoskisson & Smith, 2007; Seed et al., 2012). For that reason, our laboratory sought to verify 
if CwpV could protect the bacterial cell in a phage infection context in C. difficile.  
 
Our previous studies provided experimental evidence demonstrating that CwpV protects C. 
difficile from phage infection (Sekulovic, Ospina Bedoya, Fivian-Hughes, Fairweather, & 
Fortier, 2015a). We showed that five types of CwpV protect against three phages from the 
Siphoviridae family; φCD38-2, φCD111, and φCD146. Similarly, the types I, III and V 
(types II and IV could not be tested) protects against the infection by phages of the 
Myoviridae family; φMMP01 and φCD52 (although the protection is less strong). We also 
showed that the antiphage activity is contained in the C-terminal part of the protein. Our data 
demonstrated that the viral particles are capable of attaching to the bacterium, but further 
phage DNA replication is not detected, strongly suggesting an inhibition at the moment of 
the DNA injection (Sekulovic et al., 2015a). This mechanism could be compared to the Sie 
systems from L. lactis. Interestingly, knowing that CwpV is active against two viral families 
can suggest that the interference involves a structure, host component or a downstream 
process common to both families.  
 
The understanding of the biological and molecular mechanisms of C. difficile phage infection 
is still obscure, making the comprehension of phage-host interactions and the action of CwpV 
limited. Equally crucial, the bacterial receptors recognized by C. difficile phages were still 
unknown when I started this project. One of our hypothesis is that for CwpV interference to 
occur, the protein interacts with a structural component of the phage tail that could be 
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conserved among multiple phages. Alternatively, different phage families could use different 
injection mechanism that at one point are all affected by CwpV presence.  
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Objectives of the project 
The general research line of this project is to examine and understand on a broader level 
phage-host interactions in Clostridium difficile, using Lactococcus lactis as a model 
microorganism to study the function of the antiphage system CwpV. 
 
Although all previous data regarding CwpV function has been gathered using C. difficile as 
a host, this bacterial model does present several limitations. For example, the limited host 
range of the available phages, restrictions in the genetic manipulation of some C. difficile 
strains and lysogeny which could mask the result of phage infections. L. lactis represents an 
excellent experimental model not only because its phages are strictly lytic (and thus facilitates 
the study of antiphage systems), but also the receptor, structural biology and life cycle of its 
phages are better characterized. With our first group of objectives (#1 and #2), we seek to 
transfer this antiphage system to a more suitable host (heterologous host Lactococcus lactis) 
and test the antiphage properties against a well-studied phage, p2.  
 
In a parallel manner, another limitation to our understanding of phage-host interactions is the 
lack of an identified host receptor used by C. difficile phages. In our second group of 
objectives (#3 and #4), we seek to understand the role of SlpA, a protein of the same family 
of CwpV (that shares common characteristics), in phage infection and how the different slpA 
alleles could modify sensitivity to phages. We take as guide previous studies in C. difficile 
and phage-like particles, to address a fundamental question in phage biology: finding the role 
of a particular protein as a determinant for phage infection. 
Objective #1 
Express the antiphage protein CwpV in the heterologous host Lactococcus lactis 
Objective #2 
Assess whether CwpV could confer antiphage protection against a non-phylogenetically 
related phage. 
Objective #3 
Confirm and extend our understanding of the role of SlpA as a bacteriophage receptor 
Objective #4 
Characterize the different slpA alleles in relation to sensitivity to bacteriophage infection 
CHAPTER II 
MATERIALS AND METHODS 
 
2. Bacterial strains, plasmids, and bacteriophages 
 
A comprehensive list of bacterial strains, plasmids, and phages used in this work is presented 
in Table 2. L. lactis was routinely grown in an incubator under aerobic conditions at 30°C in 
0.5% Glucose-M17 (GM17) broth. Chloramphenicol (15 μg/mL) was added when necessary. 
C. difficile was grown in an anaerobic chamber (Coy Laboratories, anaerobic conditions H2 
10%, CO2 5%, and N2 85%) at 37°C in pre-reduced brain heart infusion (BHI) broth or TY 
broth (2% yeast extract, 3% tryptose, pH 7.4). Thiamphenicol (15 μg/ mL) or norfloxacin (12 
μg/mL) were added when necessary. E. coli was grown in aerobic conditions in Luria–
Bertani (LB) broth in an incubator with agitation at 37°C with proper antibiotics when 
necessary, chloramphenicol (25 μg/mL) or kanamycin (50 μg/mL). 
 
Table 2. List of strains, plasmids, and phages utilized in this study. 
Strain, plasmids, 
or bacteriophages 
Characteristic or description Reference or source 
Clostridium difficile   
R20291 Epidemic isolate, ribotype 027 (Stabler et al. 2009) 
R20291 slpA- 
mutant 
R20291 mutant version of the slpA gene 
(type 4, stop codon TAA in position 98) 
AvidBiotics Corp, 
2015 
CDMOB01 
R20291 slpA- containing pJAK017, slpA 
type 1 
This study 
CDMOB02 
R20291 slpA- containing pJAK023, slpA 
type 2 
This study 
CDMOB06 
R20291 slpA- containing pJAK018, slpA 
type 6 
This study 
CDMOB07 
R20291 slpA- containing pSEW027, slpA 
type 7 
This study 
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CDMOB07b 
R20291 slpA- containing pJAK001, slpA 
type 7b 
This study 
CDMOB08 
R20291 slpA- containing pJAK019, slpA 
type 8 
This study 
CDMOB09 
R20291 slpA- containing pJAK020, slpA 
type 9 
This study 
CDMOB10 
R20291 slpA- containing pJAK003, slpA 
type 10 
This study 
CDMOB11 
R20291 slpA- containing pAAM0013, slpA 
type 11 
This study 
CDMOB12 
R20291 slpA- containing pJAK021, slpA 
type 12 
This study 
CDMOB13 
R20291 slpA- containing pJAK022, slpA 
type 13 
This study 
CDMOBH2/6 
R20291 slpA- containing pJAK002, slpA 
type H2/6 
This study 
CDMOB04Rev 
R20291 slpA- complemented with WT slpA 
allele (type 4) 
(Fagan, 2015) 
   
Lactococcus lactis   
MG1363 
Gram-positive lactic acid bacterium 
extensively used in dairy industry 
(Gasson, 1983) 
NZ9000 
Derivative of MG1363 strain suitable for 
nisin regulated gene expression. The strain 
contains the regulatory genes nisR and 
nisK integrated into the pepN gene 
MoBiTec GmbH 
2010 
L. lactis pMOB100 
L. lactis NZ9000 containing 
pRPF144:usp45:ΔSigPcwpV 
This study 
L. lactis pMOB101 
L. lactis NZ9000 containing 
pNZ8010:usp45:ΔSigPcwpV 
This study 
L. lactis pNZ8010 L. lactis NZ9000 containing pNZ8010 This study 
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Escherichia coli   
TOP10 Cloning strain for pRPF plasmids Invitrogen 
MC1061 Cloning strain for pNZ plasmids.  
(Casadaban MJ, 
Cohen SN, 1980) 
CA434 
HB101 carrying plasmid R702 used for 
conjugation into C. difficile 
(Purdy et al., 2002) 
Bacteriophages   
L. lactis phage p2 Siphoviridae, 936 group 
(Moineau, Walker, 
Vedamuthu, & 
Vandenbergh, 1995) 
ΦCD38-2 Siphoviridae 
(Sekulovic, 
Meessen-Pinard, & 
Fortier, 2011) 
ΦCD111 Siphoviridae 
(Sekulovic et al., 
2014) 
ΦCD146 Siphoviridae 
(Sekulovic et al., 
2014) 
ΦCD481-1 Myoviridae 
(Sekulovic et al., 
2014) 
ΦCD481-2 Myoviridae 
(Sekulovic et al., 
2014) 
ΦCD505 Myoviridae 
(Sekulovic et al., 
2014) 
ΦCD506 Myoviridae 
(Sekulovic et al., 
2014) 
ΦCD508 Myoviridae 
(Sekulovic et al., 
2014) 
ΦMMP01 Myoviridae 
(Meessen-Pinard, 
Sekulovic, & Fortier, 
2012) 
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ΦMMP02 Myoviridae 
(Meessen-Pinard et 
al., 2012) 
ΦMMP03 Myoviridae 
(Meessen-Pinard et 
al., 2012) 
ΦMMP04 Myoviridae 
(Meessen-Pinard et 
al., 2012) 
ΦCD52 Myoviridae 
(Fortier & Moineau, 
2007) 
   
Plasmids   
pRPF144E 
pRPF144 without gusA gene. It presents a 
unique BamHI site 
(Sekulovic et al. 
2015) 
pRPF185E 
pRPF185 without gusA and unique BamHI 
site. Expression under control of the 
inducible Ptet promoter. 
(Sekulovic et al. 
2015) 
pNZ8010 
pNZ8008 with a multiple cloning site 
(MCS1), BamHI site included 
(de Ruyter et al. 
1996) 
pMOB100 
pRPF144:usp45:ΔSigPcwpV (cwpV gene 
cloned into pRPF144E, and for which the 
signal peptide has been replaced by the 
secretion signal usp45 from L. lactis) 
This study 
pMOB101 
pNZ8010:usp45:ΔSigPcwpV (cwpV gene 
cloned into pNZ8010, and for which the 
signal peptide has been replaced by the 
secretion signal usp45 from L. lactis) 
This study 
pOS200 
pRPF144:cwpV (cwpV gene cloned into 
pRPF144E) 
(Sekulovic et al. 
2015) 
pRPF233 pRPF185:slpA type 4 (Fagan 2015) 
pJAK001 pRPF185:slpA type 7b (Fagan 2015) 
pJAK002 pRPF185:slpA type H2/6 (Fagan 2015) 
pJAK003 pRPF185:slpA type 10 (Fagan 2015) 
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pJAK017 pRPF185:slpA type 1 (Fagan 2015) 
pJAK018 pRPF185:slpA type 6 (Fagan 2015) 
pJAK019 pRPF185:slpA type 8 (Fagan 2015) 
pJAK020 pRPF185:slpA type 9 (Fagan 2015) 
pJAK021 pRPF185:slpA type 12 (Fagan 2015) 
pJAK022 pRPF185:slpA type 13 (Fagan 2015) 
pJAK023 pRPF185:slpA type 2 (Fagan 2015) 
pSEW027 pRPF185:slpA type 7 (Fagan 2015) 
pAAM0013 pRPF185:slpA type 11 (Fagan 2015) 
 
2.2  Bacteriophage Amplification 
 
 Phage lysates (regularly over 109 PFU/mL) were prepared using standard phage 
amplification protocols as described previously in other studies (Cecilia Bebeacua et al., 
2013; Sekulovic, Ospina Bedoya, Fivian-Hughes, Fairweather, & Fortier, 2015b). Briefly, 
the night before the experiment we inoculated a pre-culture of a sensitive strain in 5 mL of 
GM17 or BHI at 30°C or 37°C respectively. The next morning, we reinoculated a culture of 
10 mL with 1% of the preculture. We followed the optical density (OD) during growth, and 
when the culture reached an OD of 0.1, we added salts (10 mM MgCl2 and 10 mM CaCl2 
[only 10 mM CaCl2 for phage p2]) and later the appropriate phage lysate at a multiplicity of 
infection (MOI) of 0.1. Again, we followed the OD looking for a decrease in the culture 
density, which indicates amplification of the phage. After amplification, we filtered the 
lysates through 0.45 μm filters and stored them at 4°C. 
 
2.3  Bacteriophage titer determination, spot tests, and efficiency of plaquing (EOP) 
by Top-Agar 
 
To assess phage titers, we used a standard soft agar overlay method (Fortier & Moineau, 
2009; Sekulovic et al., 2015b). Shortly, the night before the experiment, we inoculated a 
preculture of a sensitive strain in 5 mL of GM17 or BHI at 30°C or 37°C respectively. In the 
following morning, we inoculated a culture from the pre-culture at 1% in 10 mL of fresh 
broth. We followed the OD at 600nm regularly. Simultaneously, we prepared GM17 or BHI 
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with 0.5% agar (Top-Agar) maintained at a temperature of 50°C. We serially diluted the 
lysates of the phages to titer. When the bacterial culture arrived at an OD600nm of 0.4, we 
mixed in a tube 3 mL of Top-Agar, 0.5 mL of the bacterial culture, 0.1 mL of the phage lysate 
and salts (10 mM MgCl2 and 400 mM CaCl2 [10 mM CaCl2 for phage p2]). We then poured 
the tube content over Petri dishes containing GM17 or BHI bottom agar (1% agar). We 
incubated overnight at the appropriate temperature, and we counted the number of phage 
plaques, which we multiplied by the dilution times to determine the titer of the initial lysate. 
For a fast evaluation of bacterial sensitivity to phage infection, we performed spot tests, in 
which 5 μL of serially diluted phage lysates were deposited directly over a soft agar overlay 
containing a suitable bacterial host. Zones of lysis in the bacterial lawn revealed a productive 
phage infection. The efficiency of plaquing (EOP) was used in parallel to have a quantitative 
analysis of bacterial sensitivity to phage infection. Briefly, the EOP is presented as the ratio 
of the phage titer (expressed in plaque forming units PFU/mL) of a specific phage on the test 
strain by the phage titer (in PFU/mL) of the same phage on a sensitive strain of reference  
(Sekulovic et al., 2015b). Phage titers for EOPs were calculated as mentioned above. 
 
2.4  Cloning of CwpV in Lactococcus lactis 
 
The cwpV-II gene was amplified by PCR from genomic DNA (gDNA) of Clostridium 
difficile R20291. The primers for this PCR and the rest of the PCR reactions are reported in 
Table 3. All the PCR reactions were performed using a MasterCycler thermocycler, from 
Eppendorf (VWR, Mississauga, ON, Canada). The PCR program, cycles, temperatures, time, 
and general conditions are detailed in Table 4. The PCR mix was composed of 10 ng of 
gDNA, 1X PCR buffer (10 mM Tris-HCl, 50 mM KCl, and 1.5 mM MgCl2), 10 nM of the 
dNTPs mix, 1 nM of primers and 0.5 μL of PFU Turbo Polymerase. All the primers were 
synthesized by Integrated DNA Technologies (IDT, Coralville, IA). To verify the PCR 
products, we analyzed them in an agarose gel 0.8% (w/v) for the fragments over 1.5kb and 
2.0% (w/v) for the fragments under 1.5 kb, with TAE buffer and using Ethidium bromide 
staining. The fragment visualization was performed in a UV machine ImageQuant IQ 300 
(GE Healthcare, Mississauga, ON). To direct the secretion and functional expression of 
cwpV, the wild type lactococcal secretion signal usp45 from L. lactis, was amplified by PCR 
from gDNA from L. lactis MG1363. The products were cloned into two different backbone 
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plasmids, pRPF144E, and pNZ8010. The PCR products were cloned into the BamHI 
restriction site downstream of the promoters in both plasmids (de Ruyter, Kuipers, & de Vos, 
1996; Robert P Fagan & Fairweather, 2011) (Supplementary Figure 1). In all cases, the online 
web tool NEBuilder (http://nebuilder.neb.com/) was used to design gene-specific primers 
and PCR annealing temperatures. A Gibson isothermal assembly protocol (Gibson et al., 
2009) was then utilized to clone the two PCR fragments in the two plasmids backbones. The 
resulting plasmids were named pMOB100 and pMOB101 respectively (Table 2). Briefly, the 
backbone plasmids were linearized with BamHI and purified by EZ-10 spin column DNA 
cleanup kit (BioBasic, Mississauga, ON). Later, the plasmids were treated with 15 μL of 
Gibson-High Fidelity Assembly DNA cloning kit (NEB) along with equimolar ratios of cwpV 
and usp45 fragments, giving a total volume of 20 μL. The complete reaction mix was 
incubated at 50°C for 1 h, and 2 μL were used to transform 50 μL of competent E. coli cells 
using standard procedures (Sambrook & Russell, 2001). In short, the reaction mix and the 
cells were incubated for 30 minutes on ice. After that, they were exposed to a heat-shock 
during 45 seconds at 42°C and put back again on ice. E. coli TOP10 for pMOB100 and E. 
coli MC1061 for pMOB101 were the cloning and replication hosts. Clones were tested using 
Colony PCR. This type of PCR was performed based on the conditions presented above but 
adding an additional step in which after picking a single colony from a Petri dish, this one 
was put directly into the PCR tube and heated for 10 minutes at 94°C. Positive colonies 
carrying the detected constructs were verified by DNA sequencing (CRCHUL Sequencing 
Platform, Québec City, Québec).  
 
Table 3. List of primers utilized in this study 
Primer 
number 
Target gene Sequences (5’ - 3’) Reference 
Ta 
(°C) 
LCF1034 pNZ8010/usp45 
secretion signal-
FWD 
CAGGAGACTCTGCATGA
TGAAAAAAAAGATTATC
TCAGCTATTTTATTG 
This study 
61.9 
LCF1035 cwpV-IIΔsigP/usp45 
secretion signal-
REV 
TGTTGCCACAGTTTGAG
CGTAAACACCTGACAAC 
This study 
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LCF1036 usp45 secretion 
signal/cwpV-
IIΔsigP-FWD 
GTTTACGCTCAAACTGT
GGCAACAAATTTAAC 
This study 
59.2 
LCF1037 pNZ8010/cwpV-
IIΔsigP-REV 
AATTCTGCAGCCCGGTT
ATTTCATAAATCCTAGTA
TTCTTGATAAC 
This study 
LCF1075 pRPF144E/usp45 
secretion signal-
FWD 
AAATAAGGAAAAAATAA
TAAGATGAAAAAAAAGA
TTATCTCAGCTATTTTAA
TGTCTACAGTG 
This study 
59 
LCF1076 cwpV-IIΔsigP/usp45 
secretion signal-
REV 
TGTTGCCACAGTTTGAG
CGTAAACACCTGACAAC
GG 
This study 
LCF1077 usp45 secretion 
signal/cwpV-
IIΔsigP-FWD 
GTTTACGCTCAAACTGT
GGCAACAAATTTAACAG
GG 
This study 
62 LCF1078 pRPF144E/cwpV-
IIΔsigP-REV 
CGGCCGTTACTAGTGTT
ATTTCATAAATCCTAGTA
TTCTTGATAACATTAATG
CAATTGTAGTAG 
This study 
LCF899 cwpV-II-FWD NNNNGAGCTCCAGGGCA
AGAAAGATATGAAACTG
C 
Sekulovic et 
al 2015 
57.3 
LCF716 cwpV-II-REV GAACTCTCTCCACCTACT
ACATAAGATTGAG 
Sekulovic et 
al 2015 
Ta, Annealing temperature 
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Table 4. General PCR conditions 
Temperature Time Cycles 
94°C 3 to 10 minutes* Denaturation 
94°C 45 sec Denaturation 
X 45 sec Annealing 
72°C 1 min/kb of DNA Elongation 
72°C 10 min 
Final 
extension 
* 10 min for the PCR performed directly on bacterial 
colonies that we wanted to confirm as positives for the 
Gibson cloning assembly. X value changes depending 
on the Tm of the utilized primers. 35 cycles were 
applied for the denaturation, annealing and elongation 
steps. 
 
2.5  Bacterial transformation 
 
For L. lactis, the plasmids were transferred by electroporation (Electroporator 2510, 
Eppendorf) in the strain NZ9000 according to published methods (Holo & Nes, 1989). In 
short, the day before the experiment we inoculated L. lactis into 10mL of fresh GM17, and 
we incubated overnight at 30°C. The next day we transferred the culture into 400 mL of 
GM17 containing 0.5 M sucrose and 1% glycine, and we incubated at 30°C until the OD600nm 
reached 0.2. After that, we centrifuged the cell at 8000RPM, 4°C for 10 minutes. We 
eliminated the supernatant and suspended the cells in 150 mL of 0.5 M sucrose + cold 
glycerol 10%. We centrifuged again at 8000 g, 4°C for 10 minutes (we repeated the two last 
steps three times to ensure the quality of the cells). We suspended the pellet in 2 mL of 0.5 
M sucrose + 10% cold glycerol. Finally, we aliquoted 130 μL of the cells in tubes and frozen 
them at -80°C. Ready to electroporate, 40 μL competent cells were transferred into an 
electroporation cuvette along with 1μg of total plasmid DNA. The electroporation conditions 
were: 25 μF, 200Ω, and 2,5KV. Immediately after electroporation 500 μl of cold GM17 + 
0.5 M sucrose, 20 mM, MgCl2 + 2 mM CaCl2 were added to the cells. We transferred the 
cells into a tube and let them rest on ice for 10 minutes. Then we incubated the electroporated 
cells at 30°C for 2 hours. Finally, we spread the cells on GM17 agar plates with antibiotic 
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and incubated at 30°C for two days. Positives colonies carrying the plasmids were verified 
by PCR as previously described.  
 
2.5.1. Induction of cwpV expression in L. lactis  
 
To induce the expression of the recombinant CwpV protein from plasmid pNZ8010 in L. 
lactis, a clone was grown in 10 mL of GM17 to an OD600nm = 0.4 and induced with different 
subinhibitory concentrations of nisin (Sigma) at (0.1, 0.5, 1, 5 ng/mL) (de Ruyter et al., 1996; 
Zhou, Wang, Pan, & Li, 2008). Nisin is a 34 amino acids antimicrobial peptide that causes 
cell death in wild type L. lactis. The negative controls were wild type uninduced cells, as 
well as cells carrying the empty plasmid and induced with nisin. Expression of the 
recombinant protein at the surface of bacterial cells was confirmed by immunofluorescence 
as previously described (Sekulovic et al., 2015b). Briefly, bacteria from 1 mL of an overnight 
culture (induced and not induced) in GM17 were pelleted by centrifugation and suspended 
in 0.5 mL of Phosphate-buffered saline (PBS) + 1% bovine serum albumin (BSA) buffer, 
and later incubated for 30 minutes to block non-specific binding sites, followed by 2 hours 
of incubation with a rabbit anti-CwpVrptII antibody, kindly provided by Neil Fairweather 
(Imperial College, London, United Kingdom) (Reynolds et al., 2011a), that was diluted 1:100 
in the same buffer. After two 30 second washing steps in PBS 1X, the bacteria were incubated 
in the dark for 45 minutes with a secondary Alexa Fluor 568-Conjugated donkey anti-rabbit 
IgG (H+L) antibody (Life Technologies, United States), followed by three consecutive 
washing steps in PBS 1X. Finally, bacterial cells were suspended in 50 μL of sterile water, 
spotted on glass slides and observed with an Olympus IX-81 fluorescence microscope 
(Olympus) equipped with a Retiga 2000R monochrome cooled CCD camera..  
 
2.5.2. Induction of slpA expression in C. difficile  
 
In C. difficile the plasmids carrying the different alleles of SlpA were transferred by 
conjugation as previously described (Sekulovic & Fortier, 2015) into the R20291 slpA-mutant 
strain (Kindly provided by Gregory Govoni, AvidBiotics Corp., South San Francisco, 
California, USA). The plasmids contain one of the 13 SlpA types cloned from different 
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strains of C. difficile, kindly provided by Robert Fagan (University of Sheffield, Sheffield, 
United Kingdom) (Table 2). The cloning of the 13 types of slpA genes in C. difficile was 
based on the cloning vector pRPF185 containing a multicloning site under the control of the 
inducible Ptet promoter. Briefly, we started one preculture of E. coli CA434 and one 
preculture of C. difficile R20291 slpA-. Both in 5 mL of LB (Chloramphenicol 25 + 
Kanamycin 50) and BHI broth respectively. The next day we took 1 mL of E. coli CA434, 
and we washed it two times with PBS 1X (centrifuging at 4000g for 5 minutes). Later we 
took 200 μL of the C. difficile R20291 slpA- culture and we mixed it with the E. coli pellet. 
We spotted the totality of the combination on BHI 1% agar Petri dishes and incubated them 
at 37°C overnight. The next day we recovered the bacteria with 1 mL of PBS 1X, and platted 
them again (100 μL) on BHI agar (thiamphenicol 15 + Norfloxacin 12) and incubated them 
during one night at 37°C.  
 
The transformants were grown in 10 mL BHI to an OD600nm = 0.4 and induced with 
anhydrotetracycline (ATc) to a final concentration of 100 ng/mL during one night. We 
assessed the expression of the SlpA proteins using an SDS-PAGE and performing a surface 
protein extraction of the induced cultures (Figure 10). The samples were prepared as follows: 
10 mL of the induced C. difficile cultures were centrifugated at 4000 g followed by a washing 
step with PBS 1X. We suspended the pellet with 200 μL of glycine 0.2 M, pH = 2.2 and we 
incubated at room temperature for 30 minutes. We centrifugated again during 5 minutes at 
10000 g. Then we transferred 150 μL of the supernatant into a new tube, and we adjusted the 
pH to 7.5 using a solution of Tris H-Cl 1 M, pH=7.5. We mixed 6 μL of the samples and 8μl 
of loading buffer 6X (Tris-HCl 10 mM pH 7.6, 0.03% Blue bromophenol, 0.7135 M (5%) β-
mercaptoethanol, 60 mM EDTA and 60% glycerol). We deposited the sample in 
polyacrylamide gel 30% (29:1) (BioShop). The migration of the sample was performed in a 
Mini-Protean® Tetra Cell apparatus (Bio-rad, Mississauga, ON, Canada), using a voltage of 
100 V during 1 hour and 10 minutes. The gels were visualized using a ImageQuant 300 
system (GE Healthcare).  
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2.6  Bacterial survival assays 
 
Bacterial survival assays were performed as previously described with slight modifications 
(Sekulovic et al., 2014, 2015b). In brief, L. lactis and C. difficile overnight cultures were used 
to inoculate 5 mL of BHI or GM17 broth and bacteria were grown close to an OD600nm = 0.5, 
and then 0.9 ml of the culture was taken and mixed with the tested phage lysate to get an 
MOI of 1. CaCl2 was incorporated to a final concentration of 10 mM, and finally, the volume 
was completed to 1 ml using fresh BHI or GM17 broth. As a standard procedure, an 
uninfected control without the phage was performed in parallel. In all cases, the samples were 
mixed by inversion and incubated for 15 minutes at 30°C for L. lactis and 37°C for C. 
difficile. Later the aliquots were serially diluted in triplicate. Then, 0.1 mL of the serialized 
dilutions were plated on GM17 or BHI agar and incubated overnight. After that, the colonies 
were counted, and the ratio between the infected and uninfected controls was indicative of 
bacterial susceptibility to phage infection since only cells that survived the infection made 
colonies on agar. The index was expressed as survival percentage ([infected/uninfected] × 
100).  
 
Figure 10. SDS-PAGE of SlpA extractions. The presence of SlpA in the bacterial cell 
wall of Clostridium difficle was evaluated by SDS-PAGE. In the first line, the slpA- 
deficient mutant where protein was not detected. In the second line, the WT strain 
presents the two SlpA subunits. In the third line, the cell wall extraction of the slpA mutant 
complemented with the slpA type 8 (CDMOB08) shows the reestablishment of the protein 
in the cell-wall. The same procedure was performed for all slpA types. 
kDa
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2.7  Bacteriophage adsorption assays 
 
Phage adsorption assays were made as described previously without significant 
modifications (Hyman & Abedon, 2009; Sekulovic et al., 2014, 2015b). Briefly, bacteria 
from an overnight culture were started in GM17 or BHI broth and grown until exponential 
phase (OD600nm = 0.5). Then, 0.9 mL of culture was mixed with 1x10
4 PFU of the desired 
phage in the presence of salts (MgCl2 and CaCl2 for C difficile and or CaCl2 for L. lactis), 
and the culture was completed to 1 mL with sterile BHI or GM17 broth. Phages were allowed 
to adsorb for 30 minutes at 37°C for C. difficile and 30°C for L. lactis. Afterward, the cells 
were collected by centrifugation during 2 minutes. Free phages in the supernatant that did 
not adsorb were enumerated on standard soft agar overlays as described earlier and titers 
were analyzed against the initial phage input. The adsorption percentage was calculated using 
the following formula: 100 – ([residual titer/ initial titer] × 100). 
 
 
 
 
CHAPTER III 
IMPACT OF CWPV EXPRESSION ON BACTERIOPHAGE INFECTION IN 
LACTOCOCCUS LACTIS 
 
3. CwpV protects Lactococcus lactis from bacteriophage infection 
 
With the objective of verifying if in a heterologous host the expression of CwpV could protect 
against phage infection, we used the L. lactis strain NZ9000. This strain is derivative of the 
MG1363 line. It is used in standard nisin-regulated gene expression and is also susceptible 
to infection by the lactococcal phage p2 (Siphoviridae phage from the 936 group) (Moineau 
et al., 1995). We also used the wild-type strain MG1363 to replicate the phage and have a 
concentrated fresh lysate.  
 
Protein expression is one of the most important steps when testing any type of specific 
antiphage activity. As we wanted to ensure this part of the process, we cloned the R20291 
type II cwpV gene (cwpV-II) in two different plasmids; pRPF144E and pNZ8010. The first 
one is a C. difficile plasmid under the control of the constitutive promoter Pcwp2. The second 
plasmid is a L. lactis native plasmid under the control of a nisin inducible promoter. The 
presence or absence of cwpV expression in the strains was confirmed by immunofluorescence 
(Sekulovic & Fortier, 2015; Sekulovic et al., 2015b). As a pilot test, first we transformed by 
electroporation into L. lactis the plasmid pOS200 (Sekulovic, Ospina Bedoya, Fivian-
Hughes, Fairweather, & Fortier, 2015a), a pRPF144E derived vector where a complete wild-
type gene cwpV-II was cloned. The primary objective of this test was to determine if a 
C. difficile plasmid could be maintained into L. lactis, which would simplify translation of 
all experiments from C. difficile to L. lactis afterwards. However, preliminary 
immunofluorescence data showed no protein expression (data not shown). Taking into 
account previous data regarding protein expression in L. lactis (Borrero et al., 2011), the 
wild-type lactococcal secretion signal usp45 was then cloned in the vector replacing the 
native signal peptide of cwpV with the objective of directing the secretion and functional 
expression of the protein. The resulting vector was named pMOB100 and transferred by 
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electroporation into NZ9000 that does not have the cwpV gene. Its constitutive expression 
was assessed by immunofluorescence. Expression of CwpV from the pMOB100 plasmid 
showed clusters of bacteria expressing the protein, nevertheless, it was clear that expression 
was not uniform in the whole culture and only some expression spots were detected through 
all the cells (data not shown). There was also aggregation of the cells in the strain expressing 
cwpV, suggesting that the absence of a clear signal in immunofluorescence could be due to a 
technical problem (data not shown). 
 
Given that it is possible that some undetectable amount of protein might be present in the 
cellular surface, we decided to test for phage susceptibility. We could detect in a preliminary 
spot-test assay a protection of about 3 logs in the strain containing the plasmid pMOB100 
(Figure 11), suggesting that the expression was probably sufficient to provide some 
protection. In summary, this experiment first confirmed that, although not optimal, the 
pRPF144E plasmid from C. difficile can be maintained in L. lactis, and second, the plasmid 
can be used to express proteins in a constitutive manner in this host.  
 
 
Figure 11. Susceptibility of Lactococcus lactis to bacteriophage infection in spot-test 
assays. Bacterial monolayers were prepared using cells carrying the pMOB100 plasmid 
expressing cwpV-II or the empty plasmid pRPF144E. Areas of clearing after overnight 
incubation shows susceptibility to bacteriophage infection. The spot-test assay was 
repeated three times and a representative picture is shown. 
PFU
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Lactococcus Lactis MG1363 / Bacteriophage P2
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Keeping in mind the preliminary results, we wanted to improve the expression of CwpV by 
cloning the gene in the inducible vector pNZ8010 but maintain the cloning strategy where 
the cwpV signal peptide was replaced by the lactococcal secretion signal usp45. The resulting 
vector was named pMOB101 (Table 2) and transferred by electroporation into NZ9000. 
Expression of the protein was again assessed by immunofluorescence (Figure 12). 
Expression of CwpV from the pMOB101 plasmid showed a significant improvement and 
could be detected in most of the cells in the culture. It is important to underline that the 
protein expression was still not equal to the levels detected in C. difficile, and there is still 
room for adjustments in the expression strategy in L. lactis (further discussion on cellular 
aggregation is expanded in section 3.4). Equally important, immunofluorescence protocol for 
CwpV detection still could be optimized and adapted to L. lactis in order to reach similar 
results as observed with C. difficile (Sekulovic et al., 2015a). Also, alternative strategies as 
Western Blotting could be implemented for detection of CwpV expression. In summary, we 
could express the CwpV protein in the heterologous host L. lactis. 
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Subsequently, using a spot test infection assay, we evaluated the outcome of the expression 
of CwpV-II on the susceptibility to infection by the phage p2. The strain NZ9000 was 
completely sensitive to the infection by the phage as it was described in C. difficile R20291 
(Sekulovic & Fortier, 2015; Sekulovic et al., 2014, 2015b). We observed a strong reduction 
(almost complete absence) of infection in L. lactis cells that were expressing cwpV-II (Figure 
13).  
 
 
Figure 12. Immunofluorescence detection of CwpV expression. The presence of 
CwpV in the bacterial cell wall of L. lactis was evaluated by immunofluorescence using 
antibodies specifically directed against the C-terminal part of the protein. We can notice 
there is no fluorescent signal of the protein in the strain that it is not induced with nisin. 
DIC 100x 
No Nisin induction
α-CwpV 100x 
Nisin induction
Lactococcus lactis
pMOB101
Lactococcus lactis
pMOB101
Merge
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We confirmed as well that the level of resistance was proportional to the degree of protein 
induction. It is important to clarify that in a context of a spot-test assay, the multiplicity of 
infection (MOI) is particularly high (usually the lysates used in the experiments present high 
titers). Therefore, we decided to assess the effect of cwpV-II expression on the susceptibility 
to phage infection with parameters where the viruses and bacteria were in a ratio of 1:1 (MOI 
= 1). Then, we performed a bacterial survival assay in which we infected L. lactis (previously 
induced with 5 ng/mL of nisin) in broth medium with the phage p2, followed by plating of 
the bacteria that were infected. We then counted the colonies, representing residual viable 
cells. In Figure 14 we show that in L. lactis expressing cwpV-II, bacteria survived the 
 
Figure 13. Susceptibility of L. lactis to bacteriophage infection in spot-test assays. 
Bacterial monolayers were prepared with the strain NZ9000 carrying the pMOB101 
plasmid expressing cwpV type II or the empty plasmid pNZ8010 (also induced with 0.5 
ng of nisin). Areas of clearing after overnight incubation shows sensitivity to 
bacteriophage infection. The spot-test assay was repeated three times and an illustrative 
picture is shown. 
pMOB101
Lactococcus Lactis NZ9000 / Bacteriophage P2
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infection in a proportion of about 55.9 ± 12.4 %. On the other hand, only 6.3 ± 3.0 % of the 
bacteria bearing the empty plasmid pNZ8010 survived. In a similar manner, we infected L. 
lactis containing the plasmid pMOB101 but without induction, and in this case 21.3± 5.7 % 
of bacteria survived (this suggests a certain level of leakage of the inducible promoter). In 
this order of ideas, we confirmed that in a heterologous host the expression of cwpV-II 
confers phage protection. It is important to remark that we used an MOI of 1 in our bacterial 
survival test. We wanted to better access phage resistance in an infection context, and also 
take advantage of the nature of our phage, which is strictly lytic. This characteristic helped 
us to circumvent previous problems like lysogeny and resistance by previous phage infection 
(Sekulovic et al., 2015b). 
 
 
 
Figure 14. Bacterial survival assay following infection with lactococcal 
bacteriophage p2. Bacteria were mixed with bacteriophage p2 in a ratio 1:1 (MOI of 1). 
The strain NZ9000 carrying the plasmid pMOB101 (nisin induced and not induced) was 
compared with the strain NZ9000 carrying the empty plasmid pNZ8010. Colonies 
representing bacteria that survived the infection were counted and the index is expressed 
as a percentage of the ratio between infected and uninfected controls. Bars denote means 
± standard deviation (SD) of three independent biological replicates, which were each 
plated in technical triplicates. One-way ANOVA comparisons were done with NZ9000 
as the reference condition (*P < 0.05). 
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3.2  CwpV protects against infection by the siphophage p2 when expressed in 
Lactococcus lactis 
 
To further characterize and compare the CwpV protein properties against phages, we 
determined the efficiency of plaquing (EOP) (Fortier & Moineau, 2009; Sekulovic et al., 
2014). We incorporated into soft agar overlays dilutions of phage p2 lysates. With this, we 
could calculate the EOP in the L. lactis strain NZ9000 (in general terms an EOP is the 
proportion of phages that can infect a determined strain, compared to a reference strain, in 
this case, the wild-type host MG1363). CwpV blocked the infection against the siphophage 
p2, with an EOP value of 4.4 x10-2.  
 
3.3 Adsorption of bacteriophage p2 is not prevented in cells expressing cwpV 
 
The last experiments suggest that when CwpV is expressed, phage progeny is affected (fewer 
plaques). Nevertheless, phage infection could be overridden at many steps of the viral 
lifecycle. Taking into consideration the localization of CwpV in the bacterial cell wall, we 
revisited a previous hypothesis tested in our laboratory (Sekulovic et al., 2015b), which is 
whether CwpV could block phage adsorption. Adsorption is the first step of a viral infection 
where the viral particle attaches to the cell. Interference with this important step abrogates 
the whole infection process. To test this hypothesis, we performed a phage adsorption assay 
with a L. lactis strain expressing cwpV-II from the plasmid pMOB101 (previously induced 
with 5 ng/mL of nisin). A positive control of adsorption consisted in a strain that contained 
the empty plasmid pNZ8010 and does not synthesize CwpV at all. In Figure 15 we 
demonstrated that the adsorption levels were almost identical in the strain expressing CwpV 
or the one which did not, with 92.8 ± 1.0 % and 91.5 ± 2.9 % respectively. These results 
confirm that the expression of cwpV does not affect the attachment of the viral particles to 
the bacterial surface, thus confirming previous results (Sekulovic et al., 2015b), and that the 
antiphage activity involves a downstream process in the infection cycle. Also, it is known 
from previous research that CwpV does not interfere with phage DNA replication or early 
gene transcription when the phage exists in a prophage state in the bacterial genome 
(Sekulovic et al., 2015b). Consequently, taken together with all the data we corroborate that 
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CwpV might function as a non-prophage encoded superinfection exclusion system (Sie) and 
that this system can be transferred to a heterologous host to interfere with phage infection. 
 
 
3.4  Expression of CwpV in L. lactis suggests an increase in cellular aggregation  
 
As previously reported for C. difficile strain 630, overexpression of CwpV (all the types apart 
from type V) induced aggregation in broth at high density (OD600 > 10) (Reynolds, Emerson, 
de la Riva, Fagan, & Fairweather, 2011b). It was showed also that the aggregation occurred 
even early in the first hour of bacterial growth. The hypothesis for this phenomenon implies 
that this new reformed bacterial arrangement could come from CwpV-mediated auto-
aggregation. Regarding the CwpV expression in L. lactis NZ9000, we decided to grow 
overnight a bacterial culture bearing the plasmid pMOB101 and induced it with 5 ng/mL 
nisin (de Ruyter et al., 1996). In parallel, we grew another culture but with no induction. The 
cultures were started with a 1% inoculum, and they were incubated for 24h. The next day we 
observed that in both cases (with induction or without induction), the expression of cwpV-II 
in L. lactis NZ9000 did not produce a macroscopic change regarding aggregation in liquid 
 
Figure 15. Bacteriophage adsorption assay of p2 in L. lactis expressing or not CwpV 
type II. Bars denote means ± standard deviation (SD) of three independent biological 
replicates, which were also plated in technical triplicates. Unpaired t-test of data was done 
with NZ9000 carrying the plasmid pNZ8010 as the reference strain. 
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suspension. However, in a reproducible manner, we could detect clumping of the bacteria 
under microscope (for example in Figure 12). More experiments about the CwpV aggregative 
properties in heterologous host need to be done, as well as its role in bacterial colonization 
and biofilm formation.  
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CHAPTER IV 
ROLE OF SLPA IN CLOSTRIDIUM DIFFICILE BACTERIOPHAGE 
INFECTION 
 
4. Inactivation of slpA in R20291 leads to complete bacteriophage resistance, and 
its complementation restores bacteriophage susceptibility 
 
With the purpose of understanding the role of the surface protein SlpA in C. difficile phage 
infection, we used a mutant from the epidemic strain R20291 defective for the protein SlpA. 
This mutant was obtained as a result of a work where genetically modified contractile R-type 
bacteriocins (called Diffocins) from C. difficile were used to kill BI/NAP1/027-type strains. 
The mutant was isolated because of its resistance to lysis by the Diffocins. As the Diffocins 
and phages have common structural characteristics, we decided to test the role of slpA in 
phage infection. The mutant has an adenine insertion early in the sequence of the gene that 
leads to a premature TAA stop codon, creating a truncated protein (unpublished data). In 
normal infection conditions, the strain R20291 wild type is susceptible to the infection by the 
Siphoviridae family members’ ϕCD38-2, ϕCD111, and ϕCD146 (Table 1). Using a spot test 
assay, we evaluated the result of the absence of SlpA on the susceptibility to infection by 
these phages. We deposited five microliters of diluted phage lysates (from 108 to 105 PFU) 
on top of soft agar overlays containing the R20291 or R202091 slpA mutant strains. As a 
positive control, we used dilutions of Diffocins (Gebhart et al., 2015). We showed that the 
absence of SlpA from the cell surface rendered the bacterium completely insensitive to 
infection (Figure 16).  
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However, complementation of the slpA- mutant with a plasmid carrying a wild-type slpA 
allele (CDMOB04Rev) restored susceptibility to phage infection with ϕCD38-2, ϕCD111, 
and ϕCD146 (Figure 17). In both cases, the C. difficile R20291-specific bacteriocin 
(Diffocin) was used as a positive control (undiluted and dilutions of 1/4, 1/6, 1/10). 
 
 
 
Figure 16. Inactivation of slpA in R20291 leads to complete bacteriophage resistance. 
Bacterial spot tests. Five microliters of diluted phage lysates were deposited on top of soft 
agar overlays containing log-phase cultures of C. difficile strains. The C. difficile R20291-
specific bacteriocin (Diffocin) was used as a positive control. 
 
Figure 17. Complemented slpA mutant restores bacteriophage sensitivity. Spot test 
assay on the R20291WT and R20291 slpA- complemented strains. 
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4.2  The absence of SlpA leads to a reduction in the adsorption of bacteriophages 
ϕCD38-2 and ϕCD146, but not ϕCD111 
 
As stated earlier, phage adsorption is the first step of the viral infection cycle and one of the 
most important. This step is multifactorial and involves complex mechanisms that lead to the 
entry of the foreign genetic material entering to the cytoplasm. Considering the SlpA 
localization and the fact that this protein is an integral part of the bacterial cell-wall, we 
hypothesized that its absence could affect the phage attachment to the bacterial surface. We 
thus performed a phage adsorption assay with the R20291 and the R20291 slpA- strains. In 
Figure 18 we demonstrated with a phage adsorption assay that the absence of the protein 
SlpA in the slpA- mutant led to a significant reduction of about 30 to 40% in the adsorption 
of ϕCD38-2 (70.6 ± 8.1% compared to 96.4 ± 2.1% for the WT) and ϕCD146 (56.1 ± 18.6% 
compared to 90,8 ± 6,1% for the WT), respectively, whereas adsorption of ϕCD111 was not 
significantly affected (94.8 ± 3.1 % compared to 97.7 ± 1.1 % for the WT). This result 
suggests that although the absence of SlpA from the bacterial cell wall reduces the attachment 
of ϕCD38-2 and ϕCD146, the level of adsorbed phage is still important, suggesting that SlpA 
does not dictate alone the fate of the infection process. For the phage ϕCD111, there was no 
significant reduction, suggesting a slightly different mechanism of host recognition, despite 
the requirement for SlpA.  
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4.3  Complementation of the R20291 slpA- mutant with different slpA alleles changes 
the susceptibility to bacteriophage infection 
 
The cell surface is composed of a paracrystalline proteinaceous S-layer encoded by the slpA 
gene within the cwp gene cluster. The diversity and evolution of slpA and adjacent genes that 
also encode immunodominant cell surface antigens have been well characterized (Kate E 
Dingle et al., 2013; Tuomo Karjalainen et al., 2002). We sought to expand our knowledge in 
the host range effect of the various SlpA types in the infection by phages from two families 
(Siphoviridae and Myoviridae), using the advantage of having the same genetic background 
of strain R20291, which is only infected by Siphoviridae viruses but not Myoviridae viruses 
(this pattern possibly emerging due to the presence of antiphage systems or because the slpA 
type is not the appropriate one for these phages). We transferred by conjugation each of the 
12 types of slpA alleles into the strain R20291 slpA- mutant and assessed infection by phages 
ϕCD38-2, ϕCD111, ϕCD146, ϕCD481-1, ϕCD481-2, ϕCD505, ϕCD506, ϕCD508, 
ϕMMP01, ϕMMP02, ϕMMP03, ϕMMP04, and ϕCD52, using spot tests. The selection of 
these particular phages was based on the expected CRISPRs interference of the strain R20291 
 
Figure 18. The absence of SlpA leads to a reduction in the bacteriophage adsorption 
of ϕCD38-2 and ϕCD146, but not ϕCD111. Adsorption assays. Bacteria from an 
overnight culture were inoculated in TY broth and grown until exponential phase. Free 
bacteriophages in the supernatant that did not adsorb were counted on standard soft agar 
overlays and titers were compared with the initial bacteriophage inoculum. Bars denote 
means ± standard deviation (SD) of three independent biological replicates, which were 
also plated in technical triplicates. Unpaired t-test of data was done with R20291 WT as 
the reference strain. (*P < 0.05). 
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against the viruses of our phage bank, derived from our previous study (Boudry et al., 2015). 
Table 5 summarizes the results observed for each combination of slpA type/phage.  
 
 
Firstly, the host range matrix shows that the R20291 slpA- mutant was resistant to all phages 
tested, independent from their family, i.e. Siphoviridae or Myoviridae, suggesting that SlpA 
is a common phage receptor used by most, if not all phages infecting C. difficile (although 
there are other factors that determine the natural host range). Second, as previously 
emphasized, the complementation with the type 4 slpA allele (same as the wild-type strain 
R20291) restored the susceptibility to phages ϕCD38-2, ϕCD111, and ϕCD146. Similarly, 
 
Table 5. Complementation of the R20291 slpA- mutant with different slpA alleles 
changes the susceptibility to bacteriophage infection.  
 
Host range analysis. Isolate sensitivity (indicated as follows: +, sensitive; ++, moderately 
sensitive; +++, very sensitive; -, not sensitive.) is based on the intensity of the clearing 
zones. Bacteriophage families: M, Myoviridae; S, Siphoviridae. 
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the previous resistance to all phages of the Myoviridae family was maintained. Interestingly, 
complementation with the slpA alleles 8, 9, 11 and 13 restored the host range in an identical 
manner as the allele 4 did, suggesting that the three siphophages tested can use more than 
one slpA allele as a receptor to infect different hosts.  
 
Complementation with allele types 1, 6 and 10 made the R20291 strain susceptible to 
infection by the myophage ϕCD506, which has never been observed before. Similar 
observations were also made with the allele types 1, 6, 7, 10, 12 and H2/6 that conferred 
susceptibility to infection by phage ϕCD508. The allele type H2/6 allowed infection by 
phages ϕMMP02 and ϕMMP03, and allele type 1 allowed phage ϕMMP04 to infect the 
R20291 complemented strain.  
 
Of note, the slpA types 10 and 12 gave a strong bacterial lysis with phage ϕCD506 and 
ϕCD508, respectively, indicating that the complementation with those slpA types rendered 
the bacteria very sensitive to these phages. In all cases, there was no evidence in previous 
investigations of phages of the Myoviridae family infecting the epidemic strains R20291, 
besides the endogenous phi027 prophage, which is predicted to be a member of this family. 
These results thus indicate that SlpA is a primary determinant for phage infection and that 
the slpA type expressed in the cell-wall determines the susceptibility of bacterial cells to 
infection by different viruses. 
 
4.4  SlpA co-expression and host range prediction.  
 
Understanding that the SlpA protein expression on the bacterial surface of C. difficile could 
define its sensitivity to known phages, as well as phages from different families, we decided 
to test if a co-expression of two different slpA alleles would give to the bacteria a dual host-
range sensitivity. For this, we utilized the wild type strain R20291 (already expressing its 
natural chromosomal slpA type 4), and we conjugated it with the plasmid pRPF185 bearing 
the slpA allele type 12. Using a spot test assay, we evaluated the double susceptibility and 
obtained as a result that the co-expression of slpA type 4 and type 12 conferred susceptibility 
to phages ϕCD38-2, ϕCD111, and ϕCD146 (from the Siphoviridae family) in addition to the 
phage ϕCD508 (from the Myoviridae family) (Figure 19). As far as we know, this is the first 
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time that manipulation of the expression of a cell-wall protein not only brings about a new 
host range to a specific strain but also that co-expression of two different slpA alleles can 
lead to a combined susceptibility phenotype to a single strain. 
 
 
 
 
Figure 19. Co-expression of slpA type 12 in R20291 confers double susceptibility. 
Spot test assay on the R20291WT complemented with the slpA cassette 12. 
PFU
108
107
106
R20291WT + slpA cassette 12
CHAPTER V 
DISCUSSION AND CONCLUSION 
 
5. Discussion  
 
Microorganism evolution depends on a complex multitude of factors including the 
interactions with other microorganisms and genetic elements (like viruses and plasmids). In 
host-parasite relationships, each microorganism causes a reciprocal selective pressure on 
each other. The result of this dynamic is an endless arsenal of biological mechanisms that 
could ensure survival or in Lewis Carroll’s words “it takes all the running you can do to keep 
in the same place”. The main idea of this work was comprehending and delving into the 
infection mechanisms of the phages of the Gram-positive bacterium, C. difficile. More 
specifically, we wanted to test the activity of the antiphage protein CwpV from C. difficile 
into the heterologous host L. lactis. Indeed, this bacterial species is susceptible to several 
strictly lytic phages, and genetic manipulations are easier. In addition, we wanted to confirm 
a long-standing question as to whether phages could use the SlpA protein as a receptor to 
initiate infection. 
 
It is relevant to understand the effect of phages in the biology and ecology of bacterial strains 
that have importance to human health, such as C. difficile. Using L. lactis (an important 
bacterial species in the dairy industry), we provided experimental evidence in which we 
verified that the cell-wall protein CwpV from C. difficile protected L. lactis from phage 
infection. In parallel, we sought to understand the role of SlpA as a possible receptor, in 
phage infection and how the different slpA alleles could modify susceptibility to phage 
infection. 
 
We showed that the expression of CwpV type II protects against one lactococcal phage of 
the 936 group. Further data shows that the phage is capable of adsorbing to the bacterial host, 
suggesting that the inhibition of the replication cycle happens after the adsorption: at the 
phage DNA injection or another downstream process. Like it was already stated in previous 
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work from our laboratory (Sekulovic et al., 2015a), the action of CwpV is similar to other 
phage-derived resistance systems (Sie systems) (S. J. Labrie et al., 2010; Mahony, McGrath, 
Fitzgerald, & van Sinderen, 2008; McGrath, Fitzgerald, & van Sinderen, 2002). Nisin 
regulated and constitutive expression of CwpV-II from two different plasmids was enough 
to block the infection by phage p2. However, expression from the constitutive vector 
pRPF144E showed a reduced protection in spot test assays. Possibly this difference between 
protein expression was due to the non-optimal maintenance of pRPF vectors in Lactococcus 
hosts. The proper expression of CwpV is necessary for complete protection, and perhaps the 
phage-to-host ratio is fundamental for optimal protection. 
 
As we previously hypothesized in other work with CwpV, it is possible that for the antiphage 
action from CwpV, the protein should cover a large proportion of the cell surface. The natural 
expression of CwpV in wild type strains account for only 13.3% of the total cell-wall proteins 
(where the rest is mainly accounted by cell wall protein SlpA that forms a two-dimensional 
paracrystalline array in which CwpV is embedded) (Reynolds et al., 2011b). Consequently, 
a suboptimal expression of the protein from a pRFP plasmid could lead to zones where the 
bacterial cell surface may not display CwpV, and that would explain why at high MOI, 
phages can manage to infect the cell. There are still fundamental questions to address 
regarding the MOI in controlled infections and the strength of antiphage systems (here the 
latter factor tends to be taken more into account). 
 
In addition, the dose-dependent response observed in the protein induction for the plasmid 
pNZ8010 has been determined in other phage systems from lactic acid bacteria. Where 
transferring the “antiphage” gene into a well establish multi-copy plasmid leads to a stronger 
phage resistance phenotype (McGrath et al., 2002; Sun, Göhler, Heller, & Neve, 2006a). For 
example, the Sie2009 system was shown to cause complete resistance against p2 when 
expressed from the nisin-inducible expression vector pNZ8048 (Mahony et al, 2008).  
 
Then we showed that when CwpV is expressed in L. lactis, it conserved in a certain measure 
its antiphage activity, in this case toward the phage p2. The obtained result did not reach EOP 
values from previous studies with C. difficile siphophages where values < 5 x 10-7 for the 
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phage φCD38-2 were obtained (Sekulovic et al., 2015b). Nevertheless, the EOP values were 
similar to phages of the Myoviridae family where CwpV (types I, III, V) provided some 
protection against the phage φMMP01 (with EOPs of 9 x 10-3, 5.6 x 10−2, 9.7 x 10−2 
respectively). (Sekulovic et al., 2015a). Although the phage p2 is a siphophage, its genetics 
and ecology vastly differs from C. difficile phages. It is especially remarkable that CwpV is 
active against phages that can infect such divergent hosts, this could indicate that CwpV 
interferes with a conserved phage structure, host element, or step in the infection process 
common in both groups of phages. 
 
It is not the first time that an antiphage system is transferred to a heterologous host. The Ltp 
protein that is encoded by the Streptococcus thermophilus phage TP-J34 is a Sie system (EOP 
of about 10−2 in S. thermophilus) that once transferred to L. lactis, can render the bacteria 
resistant to the phage P008 (from the 936 group) (EOP < 10−9 in L. lactis), but not to other 
members of lactococcal phage species (Mahony et al., 2008; Sun, Göhler, Heller, & Neve, 
2006b). Ltp is a 42 amino acids lipoprotein-associated to the cell membrane that presents 
similarities to Sie2009 (already discussed in the section 1.9.4.3) 
 
The mechanism of infection of phage p2 starts when viral particles possibly dock to the cell-
wall: firstly, having a weak interaction between the tail adhesins and the bacterial pellicle (an 
outer layer composed of cell-wall polysaccharides). Later the specific interaction of the phage 
receptor binding protein (RBP) in the baseplate and the pellicle occurs. Leading finally to the 
baseplate activation, RBP molecular rotation and strong attaching to the saccharide receptor 
(Cecilia Bebeacua et al., 2013). Therefore, regarding the mechanism in which Sie systems 
operate, one of our first hypothesis was that CwpV could be masking an important feature of 
the cell-wall that activates the DNA injection or possibly blocks the adsorption of the viral 
particle to the host, therefore preventing the RBP from interacting with the sugar receptor of 
phage p2.  
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The data obtained in this work suggest that CwpV possibly interferes at the moment of the 
DNA injection (Figure 20). Our experiments demonstrated that adsorption of the phage was 
not prevented in L. lactis expressing CwpV, suggesting that CwpV does not impede the first 
steps of infection (unspecific, specific interactions and receptor binding). Previous research 
in C. difficile did not detect phage replication in cells expressing CwpV (Sekulovic et al., 
 
Figure 20. Proposed generalist mechanism of infection by a bacteriophage under a 
bacterial host expressing SlpA or CwpV proteins. (A) Free bacteriophage roam the 
environment for a suitable host. (B) Reversible interaction among the host cell wall 
(unknown) molecules and bacteriophage structural proteins is established (tail or capsid). 
(C) Specific interactions with SlpA as a secondary receptor may lead the final 
bacteriophage positioning. (D) Correct interplay between the bacteriophage RBP and the 
SlpA molecule guide the secondary binding and structural activation that lead to the 
injection of the viral DNA. Absence of the SlpA renders the host insensitive to the 
bacteriophage but the viral particle can still attach to the cell up to a certain extent. (D) 
(E) In the context of CwpV expression, the presence of the protein in the cell-wall 
impedes bacteriophage infection. This phenomenon may happen by preventing the 
bacteriophage from reaching the SlpA receptor or on the other hand by the direct 
interaction of CwpV repetitions with a structural component of the viral particle.  
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2015a), hence the most logical possibility points toward an interference of CwpV on the 
phage DNA injection. We hypothesize that this specific phenomenon could happen when 
CwpV interacts with a structural element of the phage tail (tail fibers, tail tube, baseplate), 
which could be structurally conserved among phage families (at least with the phages used 
in this and previous studies). 
 
Our heterologous host gives us an outstanding tool to unveil more details in the future of our 
theoretical infection model. Contrary to C. difficile phages, the knowledge on the biology 
and structure of L. lactis phages is very well studied. The bacterial receptor of p2 and related 
phages is already discovered. Phage p2 infects L. lactis using a RBP located in the distal part 
of its proteinic tail. The RBP is composed of homotrimeric proteins which form three 
domains (Spinelli et al., 2006). One of the three domains is called the receptor-recognition 
head (a seven-stranded beta-barrel). This domain has a high affinity for a specific pellicle 
phospho- polysaccharide of L. lactis, which acts as a bacterial receptor (Tremblay et al., 
2006). These features make the heterologous host L. lactis and phage p2 an interesting model 
to investigate superinfection exclusion (Sie) systems. 
 
The previous data do highlight not only the potential use of this model as a heterologous host 
(and antiphage testing) but also shows the broad spectrum that some Sie systems have. 
Mutants of the lactococcal phage P008 capable of circumventing the streptococcal Ltp 
antiphage activity were already isolated. Genome sequencing showed specific mutations in 
the gene encoding the tape measure protein (TMP), suggesting that Ltp targets this particular 
protein. Still, there is no direct experimental evidence of such interaction (C. Bebeacua et al., 
2013). Although it is tantalizing to suggest a possible interaction between CwpV and the 
TMP, additional experiments will be required to demonstrate such interaction. Our previous 
data in C. difficile agree with this, a partially truncated type of CwpV in which five of the C-
terminal repeats have been removed has an attenuated antiphage activity against siphophages, 
while on the contrary, a complete depletion of the C-terminal repeats causes a total loss of 
activity (Sekulovic et al., 2015a).  
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To date, it is still essential to isolate phages capable of overcoming the antiphage activity of 
CwpV in both C. difficile and L. lactis models. Mutant isolation can give us clues about the 
possible phage targets and determine the specific interactions of CwpV and phage 
components. Up to now, we did not isolate such mutants when phage protection was 
maximal, but additional work would be required. Equally, there are a plethora of well-known 
lactococcal phages that can be tested (M13, 712, C2 SK1, Eb1), as well as other CwpV types 
(I, III, IV, V). These assays are underway.  
 
Care and prevention plans for infection diseases rely massively on conventional antibiotic 
therapy, which inflicts an adamant selection for bacterial resistance and interfere with the 
“normal” state of protective microbiota. Consequently, there has been an emergence of 
opportunistic pathogens, such as C. difficile. These bacteria can exploit antibiotic-derived gut 
microbiota disturbances to grow and cause disease. In a particular study (Gebhart et al., 
2015), the researchers have developed alternative macromolecular agents that use contractile 
bactericidal protein complexes also known as phage-like particles (R-type bacteriocins) to 
neutralize particular C. difficile pathogens. Efficacy in a preclinical animal study point out 
that these phage-like particles secure further improvement as possible prophylactic molecules 
to impede C. difficile diseases in humans. Further investigation on the same subject (data not 
published) shows that the receptor utilized by those phage-like particles is the SlpA protein 
and the specific type of SlpA determines the lysis capabilities of a particular phage-like 
particle. Taking those results together and understanding that phages and phage-like particles 
share numerous structural features, the aim of our study was to establish the role of the S-
layer protein SlpA in phage infection of C. difficile. We obtained the first evidence of SlpA 
serving as a receptor for infection by Siphoviridae phages (φCD38-2, φCD111, and φCD146). 
Further data shows that SlpA also functions as a receptor for Myoviridae phages (phages 
ϕCD506 and ϕCD508).  
 
Until now, bacterial receptor(s) recognized by these phages to infect C. difficile were 
unknown. We hypothesized that such receptor was a surface carbohydrate, a membrane 
protein, or another surface constituent. Using a slpA- mutant from the epidemic strain R20291, 
we show that the absence of SlpA protein from the cell-wall surface renders the bacterial 
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population completely insensitive to infection by three related phages of the Siphoviridae 
family: ϕCD38-2, ϕCD111, and ϕCD146. This phage resistance was observed in spot-test 
and broth experiments. With the objective of recovering the infection phenotype against the 
same phages, we performed a complementation of the slpA- mutant with a wild-type slpA 
allele (type 4) that ultimately restored the previous susceptibility to phage infection (model 
of infection in Figure 21A, B, C).  
 
Subsequently, our experiments demonstrated a significant reduction of about 30 to 50% in 
the adsorption of ϕCD38-2 and ϕCD146 phages respectively, whereas adsorption of ϕCD111 
was unaffected. The interplay of the blockage of ϕCD111 and its adsorption are still not 
understood. Equally, for ϕCD38-2 and ϕCD146 it is still possible that a diminution, but not 
a complete depletion in the adsorption level of a phage to a host could affect significantly 
enough the infection process to prevent a detectable infection. This kind of phenomenon has 
been registered already in L. lactis., where the phage bIL67 from the genus C2virus does not 
infect very well the strain DGCC7271 (EOP <1×10−8), however it attaches to the cell 
reaching an adsorption rate of 67.3±8.0 % (Millen & Romero, 2016). Interestingly, although 
C. difficile siphophages are closely related in structure and gene homology, they do not share 
the same host spectra (Sekulovic et al., 2014). Our data suggest that slight genetic differences 
(point mutations, small indels) account for the different adsorption values of the phage 
ϕCD111 respecting ϕCD38-2 and ϕCD146.  
 
Phages are omnipresent in the gut ecosystem. Important efforts in the last decade have aimed 
to understand the role of viral populations in the control and shape of local resident bacterial 
populations (microbiota), that are ultimately linked to the heath state of an individual. From 
that perspective, investigating the “port of entry” of these phages to the bacterial cell is of 
extreme importance. Equally significant, thanks to PCR technics and genome sequencing, 
the epidemiology, evolution, and genetic diversity of C. difficile are better understood. C. 
difficile has a diverse population structure that results in hundreds of strain types. Researchers 
using whole-genome sequencing (Kate E Dingle et al., 2013) of 57 C. difficile isolates, 
representative of the population structure and various clinical phenotypes, performed 
phylogenetic analyses on the genomic regions (>63 kb) including the cwp cluster (and slpA 
 
 
72 
72 
inside). The research stated a high genetic diversity across the cwp cluster peaked within the 
slpA gene, cwp66 (adhesin), and secA2 (secretory translocase). These genes formed a 
cassette, and 12 different variants were recognized. We transformed and complemented by 
conjugation the R20291 slpA- mutant with each of the 12 slpA alleles. We determined that 
complementation of the slpA- mutant with 4 (out of 12) variant slpA alleles restored 
susceptibility to ϕCD146, ϕCD38-2, and ϕCD111 phage infection. Nevertheless, even more 
interesting, five of the twelve alleles conferred susceptibility to other phages of the 
Myoviridae family that have never been reported to infect the R20291 strain. Understanding 
the last results, we wanted to predict if the co-expression of two different types of SlpA could 
render a population of bacteria multi-sensitive to two groups of phages. We observed that the 
co-expression of the slpA type 12 and type 4 (naturally expressed from the chromosomal 
gene) in R20291 confers double susceptibility to phages of two different viral families. To 
our knowledge, this is the first time the expression of SlpA in a particular C. difficile strain 
can render a strain sensitive to structurally and genetically different phage groups. As of 
today, hundreds of strains have been characterized and sequenced. Yet, many strains are still 
to discover and their characterization might lead to the identification of new configurations 
of slpA and cwpV alleles. On the other side of the equation, C. difficile phage characterization 
is still a field in development. Taking all this together, it is necessary to describe all these 
bacterial strains and phages. The more information we gather about them, the more 
understanding we will get regarding the role of the bacterial surface proteins in phage 
infection. Finally, phage-host interaction is a highly complex field. Susceptibility to a 
particular phage does not rely solely on the presence of a suitable surface receptor. Also, the 
presence of CRISPR systems, R-M systems, and other prophages that can provide repressor-
mediated immunity, defines the host spectrum of a strain.  
 
5.2  Conclusion 
 
In natural conditions and in an ecological context, bacteria and phages are constantly 
evolving (dying or becoming resistant). Phage infection creates an evolutionary pressure on 
bacteria to innovate different means of survival. Adsorption impairment, blocking DNA 
injection, R-M systems, CRISPR-Cas systems among others are the result of the infinite 
evolutionary war of adaptation and counter-adaptation. From these mechanisms, regular and 
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phase-variable antiphage (Sie) systems such as CwpV emerges as highly relevant in 
circumstances where multiple phage predators are present in the environment. The 
development and establishment of study models is critical to understand such evolutionary 
relationships and resultant mechanisms. Having that in mind, L. lactis is a crucial tool to test 
other lactococcal phages along with other types of CwpV to determine the specific 
interactions among this anti-phage system and bacterial viruses. Although promising 
candidates for phage protection have been in development in recent years (for example the 
well-known Abi systems), this anti-phage system can be transferred to important industrial 
hosts (as L. lactis is in the dairy industry) to be used in culture protection and other 
biotechnological applications where phage attacks cause economic burden. On the other hand, 
clinical and in vivo tests are necessary to understand how a phase-variable antiphage system 
can protect subpopulations of bacteria from lytic phage attacks during gut colonization. In 
the same order of ideas, it is of fundamental importance to understand how phages enter to 
the cell and which receptors they use to complete the viral replication cycle. 
 
The fast emergence of highly resistant bacterial pathogens is occurring word-wide due to the 
overuse or misuse of antibiotics. This crisis imposes a threat that could kill millions of 
persons. New drug development by the pharmaceutical industry does not catch up with the 
apparition of emergent resistant bacteria. In this way, phage therapy (the therapeutic use of 
lytic phages to treat bacterial infections) represents an interesting alternative to antibiotics. 
Phages can be targeted more specifically than most antibiotics, thus not affecting other 
important bacteria and the imbalance of the gut microbiota. However, in the context of this 
research, this knowledge could lead to a panorama where the usage of phages can be 
ameliorated. Firstly, by sequencing strains and looking for specific types of slpA and 
selecting phages that can use that slpA to enter to cell and lyse the host. Second, and most 
importantly, by phage RBP swapping. In absence of appropriate natural phages, changing 
the host range of a phage by swapping the RBP from other phages could become a useful 
tool for delivering genetically modified phages (in phage therapy cocktails) that could be 
directed to C. difficile during gut infection.  
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ANNEXES 
 
 
 
Supplementary figure 1. pRPF144E is a pRPF144 plasmid without gusA and with a 
unique BamHI site, also pNZ8010 is a pNZ8008 plasmid without gusA and with a unique 
MCS1. 
pRPF144 
pNZ8008 
